This Marijuana Stock Is Now ‘Too Expensive,’ Analyst Says_老虎社区_美港股上老虎

This Marijuana Stock Is Now ‘Too Expensive,’ Analyst Says

Barrons2021-02-25

Canopy Growth shares were rising on Wednesday, along with its Canadian cannabis peers. An analyst at Jefferies says the stock is now “too expensive.” Owen Bennett lowered his rating on Canopy stock (...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

StormsRiders
·2021-02-26
[可爱]
回复
1
举报
收起
- StormsRiders:
  Just commenting
  2021-02-28
  回复
  举报
- StormsRiders:
  Just commenting again.
  2021-02-28
  回复
  举报
AT2020
·2021-02-26
Over value
回复
点赞
举报
TriciaChang
·2021-02-26
weedzz
回复
1
举报
Matchapie
·2021-02-25
expensive is an understatement
回复
点赞
举报
spin37gy
·2021-02-25
Its not too expensive because i bought it at high price.. 😭
回复
1
举报
不是那么好割的小韭菜
·2021-02-25
Bullshit
回复
点赞
举报
Mageswari
·2021-02-25
Hmmmmm
回复
点赞
举报
JJ88
·2021-02-25
😮
回复
2
举报
kuppi
·2021-02-25
There are penny stocks available also.SNDL seems to be a good deal
回复
点赞
举报
收起
- dawnyong:
  Tt
  2021-02-25
  回复
  举报
CherilynC
·2021-02-25
It’s never too expensive
回复
点赞
举报
WSBApes
·2021-02-25
Like and comment
回复
点赞
举报
Lamshiying
·2021-02-25
Hold for long term
回复
点赞
举报
新運股
·2021-02-25
Expensive can become more expensive
回复
4
举报
收起
- 新運股:
  Haha
  2021-02-25
  回复
  举报
- killuz:
  hahaha
  2021-02-25
  回复
  举报
Ewald
·2021-02-25
I don't think so...
回复
3
举报
收起
- Shermantanjs:
  Wheeee
  2021-02-25
  回复
  举报
Han96
·2021-02-25
😊
回复
2
举报
KLS
·2021-02-25
Pls comemnt on my comment
回复
4
举报
收起
- Adnand:
  commented!
  2021-02-25
  回复
  举报
- Shermantanjs:
  Commented
  2021-02-25
  回复
  举报
Vicwoo
·2021-02-25
Hmmm
回复
3
举报
收起
- KLS:
  buy
  2021-02-25
  回复
  举报
DanTEOHH
·2021-02-25
What do you guys think?
回复
3
举报
收起
- KLS:
  buy
  2021-02-25
  回复
  举报
XKT1234
·2021-02-25
Nice
回复
3
举报
收起
- francis3:
  But not hood
  2021-02-25
  回复
  举报

热议股票

7x24

全部

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

关注我们

{"i18n":{"language":"zh_CN"},"data":{"share":"https://www.laohu8.com/m/news/1122955763?lang=zh_CN&edition=full","thumbnail":"","is_english":true,"pubTime":"2021-02-25 15:12","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1122955763","market":"us","top_or_hot":-1,"title":"This Marijuana Stock Is Now ‘Too Expensive,’ Analyst Says","media":"Barrons","content":"<div>\n<p>Canopy Growth shares were rising on Wednesday, along with its Canadian cannabis peers. An analyst at Jefferies says the stock is now “too expensive.”\nOwen Bennett lowered his rating on Canopy stock (...</p>\n\n<a href=\"https://www.barrons.com/articles/this-cannabis-stock-is-now-too-expensive-analyst-says-51614198173?mod=hp_DAY_9\">网页链接</a>\n\n</div>\n","source":"lsy1601382232898","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>This Marijuana Stock Is Now ‘Too Expensive,’ Analyst Says</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThis Marijuana Stock Is Now ‘Too Expensive,’ Analyst Says\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-02-25 15:12 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.barrons.com/articles/this-cannabis-stock-is-now-too-expensive-analyst-says-51614198173?mod=hp_DAY_9><strong>Barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Canopy Growth shares were rising on Wednesday, along with its Canadian cannabis peers. An analyst at Jefferies says the stock is now “too expensive.”\nOwen Bennett lowered his rating on Canopy stock (...</p>\n\n<a href=\"https://www.barrons.com/articles/this-cannabis-stock-is-now-too-expensive-analyst-says-51614198173?mod=hp_DAY_9\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":null,"symbol_name":null,"start_time":0,"source_url":"https://www.barrons.com/articles/this-cannabis-stock-is-now-too-expensive-analyst-says-51614198173?mod=hp_DAY_9","article_id":"1122955763","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1122955763","pubTimestamp":1614237149,"sourceInfo":{"source_id":"lsy1601382232898","name":"Barrons"},"weMediaInfo":null,"summary":"Canopy Growth shares were rising on Wednesday, along with its Canadian cannabis peers. An analyst at","collect":0,"end_time":0,"defaultTopTitle":"barrons.com","property":[],"viewcount":null,"language":"en","relate_stocks":{},"translate_title":"分析师说，这种大麻库存现在“太贵了”","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ACB":0.9,"APHA":0.9,"CGC":0.9,"CRON":0.9,"MJ":0.9,"SNDL":0.9},"content_text":"Canopy Growth shares were rising on Wednesday, along with its Canadian cannabis peers. An analyst at Jefferies says the stock is now “too expensive.”\nOwen Bennett lowered his rating on Canopy stock (ticker: CGC) to Underperform from Hold, though he upped his price target to $23.03 from $21.10. He argues the stock’s valuation, relative to peers, is deservedly higher due to its opportunities to enter the U.S. market when it’s legal to do so. Yet he argues investors shouldn’t play U.S. legalization with the stock at these levels.\nAs Barron’s note dearlier this month, popular U.S. growers includeCuraleaf Holdings(CURLF),Trulieve Cannabis(TCNNF),Green Thumb Industries(GTBIF), and Cresco Labs(CRLBF).\nGiven that Canopy and the U.S. grower it has a contingent deal to acquire, Acreage Holdings, are losing money, Bennett sees other U.S. growers with superior fundamental outlooks. Meanwhile, he says, the Canadian market is still in a period of transition following industrywide missteps in the rollout of legal cannabis. While he sees some encouraging signs, he argues it is still too early to turn bullish on that market.\nBennett also maintained an Underperform rating onAurora Cannabisshares (ACB) in a note on Wednesday, though he raised his price target to $7.49 from $3.58. He said the company’s second-quarter results, reported earlier this month, “only reinforced our concerns on its underlying business.”\n“First, Canadian sales pressures were more pronounced than we had assumed, with little improvement on the margin profile,” Bennett wrote. “Second, given the near-term debt overhang and its high cash burn rate, we raise questions marks on whether Aurora’s balance sheet is strong enough to support a potential US push.”\nThe downgrade hasn’t scared investors away, at least not yet. Canopy stock was up 0.8%, at $35.6, in recent trading. Aurora stock was up 3.8%, at $11.64.ETFMG Alternative Harvest(MJ), a cannabis-focused exchange-traded fund, was up 4.4%, while the S&P 500 was up 1.1%.","kind":null,"is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":368631400,"gmtCreate":1614315772600,"gmtModify":1703476254249,"author":{"id":"3575778576577621","authorId":"3575778576577621","name":"StormsRiders","avatar":"https://static.tigerbbs.com/9458edc7e400a8e64d615784bffb8ceb","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3575778576577621","idStr":"3575778576577621"},"htmlText":"[可爱]&nbsp;","listText":"[可爱]&nbsp;","text":"[可爱]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/368631400","repostId":1122955763,"repostType":4,"repost":{"id":"1122955763","pubTimestamp":1614237149,"share":"https://www.laohu8.com/m/news/1122955763?lang=&edition=full","pubTime":"2021-02-25 15:12","market":"us","language":"en","title":"This Marijuana Stock Is Now ‘Too Expensive,’ Analyst Says","url":"https://stock-news.laohu8.com/highlight/detail?id=1122955763","media":"Barrons","summary":"Canopy Growth shares were rising on Wednesday, along with its Canadian cannabis peers. An analyst at","content":"<p>Canopy Growth&nbsp;shares were rising on Wednesday, along with its Canadian cannabis peers. An analyst at Jefferies says the stock is now “too expensive.”</p>\n<p>Owen Bennett&nbsp;lowered his rating on Canopy stock (ticker: CGC) to Underperform from Hold, though he upped his price target to $23.03 from $21.10. He argues the stock’s valuation, relative to peers, is deservedly higher due to its opportunities to enter the U.S. market when it’s legal to do so. Yet he argues investors shouldn’t play U.S. legalization with the stock at these levels.</p>\n<p>As&nbsp;Barron’s&nbsp;note&nbsp;dearlier this month, popular U.S. growers includeCuraleaf Holdings(CURLF),Trulieve Cannabis(TCNNF),Green Thumb Industries(GTBIF), and&nbsp;Cresco Labs(CRLBF).</p>\n<p>Given that Canopy and the U.S. grower it has a contingent deal to acquire, Acreage Holdings, are losing money, Bennett sees other U.S. growers with superior fundamental outlooks. Meanwhile, he says, the Canadian market is still in a period of transition following industrywide missteps in the rollout of legal cannabis. While he sees some encouraging signs, he argues it is still too early to turn bullish on that market.</p>\n<p>Bennett also maintained an Underperform rating onAurora Cannabisshares (ACB) in a note on Wednesday, though he raised his price target to $7.49 from $3.58. He said the company’s second-quarter results, reported earlier this month, “only reinforced our concerns on its underlying business.”</p>\n<p>“First, Canadian sales pressures were more pronounced than we had assumed, with little improvement on the margin profile,” Bennett wrote. “Second, given the near-term debt overhang and its high cash burn rate, we raise questions marks on whether Aurora’s balance sheet is strong enough to support a potential US push.”</p>\n<p>The downgrade hasn’t scared investors away, at least not yet. Canopy stock was up 0.8%, at $35.6, in recent trading. Aurora stock was up 3.8%, at $11.64.ETFMG Alternative Harvest(MJ), a cannabis-focused exchange-traded fund, was up 4.4%, while the&nbsp;S&amp;P 500&nbsp;was up 1.1%.</p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>This Marijuana Stock Is Now ‘Too Expensive,’ Analyst Says</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThis Marijuana Stock Is Now ‘Too Expensive,’ Analyst Says\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-02-25 15:12 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.barrons.com/articles/this-cannabis-stock-is-now-too-expensive-analyst-says-51614198173?mod=hp_DAY_9><strong>Barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Canopy Growth shares were rising on Wednesday, along with its Canadian cannabis peers. An analyst at Jefferies says the stock is now “too expensive.”\nOwen Bennett lowered his rating on Canopy stock (...</p>\n\n<a href=\"https://www.barrons.com/articles/this-cannabis-stock-is-now-too-expensive-analyst-says-51614198173?mod=hp_DAY_9\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CRON":"Cronos Group Inc.","CGC":"Canopy Growth Corporation","MJ":"Amplify Alternative Harvest ETF","ACB":"奥罗拉大麻公司","APHA":"Aphria Inc.","SNDL":"SNDL Inc."},"source_url":"https://www.barrons.com/articles/this-cannabis-stock-is-now-too-expensive-analyst-says-51614198173?mod=hp_DAY_9","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1122955763","content_text":"Canopy Growth shares were rising on Wednesday, along with its Canadian cannabis peers. An analyst at Jefferies says the stock is now “too expensive.”\nOwen Bennett lowered his rating on Canopy stock (ticker: CGC) to Underperform from Hold, though he upped his price target to $23.03 from $21.10. He argues the stock’s valuation, relative to peers, is deservedly higher due to its opportunities to enter the U.S. market when it’s legal to do so. Yet he argues investors shouldn’t play U.S. legalization with the stock at these levels.\nAs Barron’s note dearlier this month, popular U.S. growers includeCuraleaf Holdings(CURLF),Trulieve Cannabis(TCNNF),Green Thumb Industries(GTBIF), and Cresco Labs(CRLBF).\nGiven that Canopy and the U.S. grower it has a contingent deal to acquire, Acreage Holdings, are losing money, Bennett sees other U.S. growers with superior fundamental outlooks. Meanwhile, he says, the Canadian market is still in a period of transition following industrywide missteps in the rollout of legal cannabis. While he sees some encouraging signs, he argues it is still too early to turn bullish on that market.\nBennett also maintained an Underperform rating onAurora Cannabisshares (ACB) in a note on Wednesday, though he raised his price target to $7.49 from $3.58. He said the company’s second-quarter results, reported earlier this month, “only reinforced our concerns on its underlying business.”\n“First, Canadian sales pressures were more pronounced than we had assumed, with little improvement on the margin profile,” Bennett wrote. “Second, given the near-term debt overhang and its high cash burn rate, we raise questions marks on whether Aurora’s balance sheet is strong enough to support a potential US push.”\nThe downgrade hasn’t scared investors away, at least not yet. Canopy stock was up 0.8%, at $35.6, in recent trading. Aurora stock was up 3.8%, at $11.64.ETFMG Alternative Harvest(MJ), a cannabis-focused exchange-traded fund, was up 4.4%, while the S&P 500 was up 1.1%.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":3683321,"gmtCreate":1614518790567,"gmtModify":1635760228232,"authorId":3575778576577621,"author":{"id":3575778576577621,"idStr":"3575778576577621","authorId":3575778576577621,"name":"StormsRiders","avatar":"https://static.tigerbbs.com/9458edc7e400a8e64d615784bffb8ceb","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":368631400,"type":1,"supId":0,"prevId":0,"content":"Just commenting","text":"Just commenting","html":"Just commenting"},{"id":3683323,"gmtCreate":1614518800729,"gmtModify":1635760228015,"authorId":3575778576577621,"author":{"id":3575778576577621,"idStr":"3575778576577621","authorId":3575778576577621,"name":"StormsRiders","avatar":"https://static.tigerbbs.com/9458edc7e400a8e64d615784bffb8ceb","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":368631400,"type":1,"supId":0,"prevId":0,"content":"Just commenting again.","text":"Just commenting again.","html":"Just commenting again."}],"langContent":"CN"},{"id":368188620,"gmtCreate":1614300209460,"gmtModify":1703475999639,"author":{"id":"3567830819209184","authorId":"3567830819209184","name":"AT2020","avatar":"https://static.tigerbbs.com/468bfa3dd7cae23eaf245b3c5e1de6ea","vip":1,"crmLevel":5,"crmLevelSwitch":0,"authorIdStr":"3567830819209184","idStr":"3567830819209184"},"htmlText":"Over value&nbsp;","listText":"Over value&nbsp;","text":"Over value","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/368188620","repostId":1122955763,"repostType":4,"repost":{"id":"1122955763","pubTimestamp":1614237149,"share":"https://www.laohu8.com/m/news/1122955763?lang=&edition=full","pubTime":"2021-02-25 15:12","market":"us","language":"en","title":"This Marijuana Stock Is Now ‘Too Expensive,’ Analyst Says","url":"https://stock-news.laohu8.com/highlight/detail?id=1122955763","media":"Barrons","summary":"Canopy Growth shares were rising on Wednesday, along with its Canadian cannabis peers. An analyst at","content":"<p>Canopy Growth&nbsp;shares were rising on Wednesday, along with its Canadian cannabis peers. An analyst at Jefferies says the stock is now “too expensive.”</p>\n<p>Owen Bennett&nbsp;lowered his rating on Canopy stock (ticker: CGC) to Underperform from Hold, though he upped his price target to $23.03 from $21.10. He argues the stock’s valuation, relative to peers, is deservedly higher due to its opportunities to enter the U.S. market when it’s legal to do so. Yet he argues investors shouldn’t play U.S. legalization with the stock at these levels.</p>\n<p>As&nbsp;Barron’s&nbsp;note&nbsp;dearlier this month, popular U.S. growers includeCuraleaf Holdings(CURLF),Trulieve Cannabis(TCNNF),Green Thumb Industries(GTBIF), and&nbsp;Cresco Labs(CRLBF).</p>\n<p>Given that Canopy and the U.S. grower it has a contingent deal to acquire, Acreage Holdings, are losing money, Bennett sees other U.S. growers with superior fundamental outlooks. Meanwhile, he says, the Canadian market is still in a period of transition following industrywide missteps in the rollout of legal cannabis. While he sees some encouraging signs, he argues it is still too early to turn bullish on that market.</p>\n<p>Bennett also maintained an Underperform rating onAurora Cannabisshares (ACB) in a note on Wednesday, though he raised his price target to $7.49 from $3.58. He said the company’s second-quarter results, reported earlier this month, “only reinforced our concerns on its underlying business.”</p>\n<p>“First, Canadian sales pressures were more pronounced than we had assumed, with little improvement on the margin profile,” Bennett wrote. “Second, given the near-term debt overhang and its high cash burn rate, we raise questions marks on whether Aurora’s balance sheet is strong enough to support a potential US push.”</p>\n<p>The downgrade hasn’t scared investors away, at least not yet. Canopy stock was up 0.8%, at $35.6, in recent trading. Aurora stock was up 3.8%, at $11.64.ETFMG Alternative Harvest(MJ), a cannabis-focused exchange-traded fund, was up 4.4%, while the&nbsp;S&amp;P 500&nbsp;was up 1.1%.</p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>This Marijuana Stock Is Now ‘Too Expensive,’ Analyst Says</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThis Marijuana Stock Is Now ‘Too Expensive,’ Analyst Says\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-02-25 15:12 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.barrons.com/articles/this-cannabis-stock-is-now-too-expensive-analyst-says-51614198173?mod=hp_DAY_9><strong>Barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Canopy Growth shares were rising on Wednesday, along with its Canadian cannabis peers. An analyst at Jefferies says the stock is now “too expensive.”\nOwen Bennett lowered his rating on Canopy stock (...</p>\n\n<a href=\"https://www.barrons.com/articles/this-cannabis-stock-is-now-too-expensive-analyst-says-51614198173?mod=hp_DAY_9\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CRON":"Cronos Group Inc.","CGC":"Canopy Growth Corporation","MJ":"Amplify Alternative Harvest ETF","ACB":"奥罗拉大麻公司","APHA":"Aphria Inc.","SNDL":"SNDL Inc."},"source_url":"https://www.barrons.com/articles/this-cannabis-stock-is-now-too-expensive-analyst-says-51614198173?mod=hp_DAY_9","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1122955763","content_text":"Canopy Growth shares were rising on Wednesday, along with its Canadian cannabis peers. An analyst at Jefferies says the stock is now “too expensive.”\nOwen Bennett lowered his rating on Canopy stock (ticker: CGC) to Underperform from Hold, though he upped his price target to $23.03 from $21.10. He argues the stock’s valuation, relative to peers, is deservedly higher due to its opportunities to enter the U.S. market when it’s legal to do so. Yet he argues investors shouldn’t play U.S. legalization with the stock at these levels.\nAs Barron’s note dearlier this month, popular U.S. growers includeCuraleaf Holdings(CURLF),Trulieve Cannabis(TCNNF),Green Thumb Industries(GTBIF), and Cresco Labs(CRLBF).\nGiven that Canopy and the U.S. grower it has a contingent deal to acquire, Acreage Holdings, are losing money, Bennett sees other U.S. growers with superior fundamental outlooks. Meanwhile, he says, the Canadian market is still in a period of transition following industrywide missteps in the rollout of legal cannabis. While he sees some encouraging signs, he argues it is still too early to turn bullish on that market.\nBennett also maintained an Underperform rating onAurora Cannabisshares (ACB) in a note on Wednesday, though he raised his price target to $7.49 from $3.58. He said the company’s second-quarter results, reported earlier this month, “only reinforced our concerns on its underlying business.”\n“First, Canadian sales pressures were more pronounced than we had assumed, with little improvement on the margin profile,” Bennett wrote. “Second, given the near-term debt overhang and its high cash burn rate, we raise questions marks on whether Aurora’s balance sheet is strong enough to support a potential US push.”\nThe downgrade hasn’t scared investors away, at least not yet. Canopy stock was up 0.8%, at $35.6, in recent trading. Aurora stock was up 3.8%, at $11.64.ETFMG Alternative Harvest(MJ), a cannabis-focused exchange-traded fund, was up 4.4%, while the S&P 500 was up 1.1%.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":368356981,"gmtCreate":1614295314243,"gmtModify":1703475903915,"author":{"id":"3560421500323385","authorId":"3560421500323385","name":"TriciaChang","avatar":"https://static.tigerbbs.com/5cb6619edb253a8bb8b2776c7d9b0e02","vip":1,"crmLevel":6,"crmLevelSwitch":0,"authorIdStr":"3560421500323385","idStr":"3560421500323385"},"htmlText":"weedzz","listText":"weedzz","text":"weedzz","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/368356981","repostId":1122955763,"repostType":4,"repost":{"id":"1122955763","pubTimestamp":1614237149,"share":"https://www.laohu8.com/m/news/1122955763?lang=&edition=full","pubTime":"2021-02-25 15:12","market":"us","language":"en","title":"This Marijuana Stock Is Now ‘Too Expensive,’ Analyst Says","url":"https://stock-news.laohu8.com/highlight/detail?id=1122955763","media":"Barrons","summary":"Canopy Growth shares were rising on Wednesday, along with its Canadian cannabis peers. An analyst at","content":"<p>Canopy Growth&nbsp;shares were rising on Wednesday, along with its Canadian cannabis peers. An analyst at Jefferies says the stock is now “too expensive.”</p>\n<p>Owen Bennett&nbsp;lowered his rating on Canopy stock (ticker: CGC) to Underperform from Hold, though he upped his price target to $23.03 from $21.10. He argues the stock’s valuation, relative to peers, is deservedly higher due to its opportunities to enter the U.S. market when it’s legal to do so. Yet he argues investors shouldn’t play U.S. legalization with the stock at these levels.</p>\n<p>As&nbsp;Barron’s&nbsp;note&nbsp;dearlier this month, popular U.S. growers includeCuraleaf Holdings(CURLF),Trulieve Cannabis(TCNNF),Green Thumb Industries(GTBIF), and&nbsp;Cresco Labs(CRLBF).</p>\n<p>Given that Canopy and the U.S. grower it has a contingent deal to acquire, Acreage Holdings, are losing money, Bennett sees other U.S. growers with superior fundamental outlooks. Meanwhile, he says, the Canadian market is still in a period of transition following industrywide missteps in the rollout of legal cannabis. While he sees some encouraging signs, he argues it is still too early to turn bullish on that market.</p>\n<p>Bennett also maintained an Underperform rating onAurora Cannabisshares (ACB) in a note on Wednesday, though he raised his price target to $7.49 from $3.58. He said the company’s second-quarter results, reported earlier this month, “only reinforced our concerns on its underlying business.”</p>\n<p>“First, Canadian sales pressures were more pronounced than we had assumed, with little improvement on the margin profile,” Bennett wrote. “Second, given the near-term debt overhang and its high cash burn rate, we raise questions marks on whether Aurora’s balance sheet is strong enough to support a potential US push.”</p>\n<p>The downgrade hasn’t scared investors away, at least not yet. Canopy stock was up 0.8%, at $35.6, in recent trading. Aurora stock was up 3.8%, at $11.64.ETFMG Alternative Harvest(MJ), a cannabis-focused exchange-traded fund, was up 4.4%, while the&nbsp;S&amp;P 500&nbsp;was up 1.1%.</p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>This Marijuana Stock Is Now ‘Too Expensive,’ Analyst Says</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThis Marijuana Stock Is Now ‘Too Expensive,’ Analyst Says\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-02-25 15:12 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.barrons.com/articles/this-cannabis-stock-is-now-too-expensive-analyst-says-51614198173?mod=hp_DAY_9><strong>Barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Canopy Growth shares were rising on Wednesday, along with its Canadian cannabis peers. An analyst at Jefferies says the stock is now “too expensive.”\nOwen Bennett lowered his rating on Canopy stock (...</p>\n\n<a href=\"https://www.barrons.com/articles/this-cannabis-stock-is-now-too-expensive-analyst-says-51614198173?mod=hp_DAY_9\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CRON":"Cronos Group Inc.","CGC":"Canopy Growth Corporation","MJ":"Amplify Alternative Harvest ETF","ACB":"奥罗拉大麻公司","APHA":"Aphria Inc.","SNDL":"SNDL Inc."},"source_url":"https://www.barrons.com/articles/this-cannabis-stock-is-now-too-expensive-analyst-says-51614198173?mod=hp_DAY_9","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1122955763","content_text":"Canopy Growth shares were rising on Wednesday, along with its Canadian cannabis peers. An analyst at Jefferies says the stock is now “too expensive.”\nOwen Bennett lowered his rating on Canopy stock (ticker: CGC) to Underperform from Hold, though he upped his price target to $23.03 from $21.10. He argues the stock’s valuation, relative to peers, is deservedly higher due to its opportunities to enter the U.S. market when it’s legal to do so. Yet he argues investors shouldn’t play U.S. legalization with the stock at these levels.\nAs Barron’s note dearlier this month, popular U.S. growers includeCuraleaf Holdings(CURLF),Trulieve Cannabis(TCNNF),Green Thumb Industries(GTBIF), and Cresco Labs(CRLBF).\nGiven that Canopy and the U.S. grower it has a contingent deal to acquire, Acreage Holdings, are losing money, Bennett sees other U.S. growers with superior fundamental outlooks. Meanwhile, he says, the Canadian market is still in a period of transition following industrywide missteps in the rollout of legal cannabis. While he sees some encouraging signs, he argues it is still too early to turn bullish on that market.\nBennett also maintained an Underperform rating onAurora Cannabisshares (ACB) in a note on Wednesday, though he raised his price target to $7.49 from $3.58. He said the company’s second-quarter results, reported earlier this month, “only reinforced our concerns on its underlying business.”\n“First, Canadian sales pressures were more pronounced than we had assumed, with little improvement on the margin profile,” Bennett wrote. “Second, given the near-term debt overhang and its high cash burn rate, we raise questions marks on whether Aurora’s balance sheet is strong enough to support a potential US push.”\nThe downgrade hasn’t scared investors away, at least not yet. Canopy stock was up 0.8%, at $35.6, in recent trading. Aurora stock was up 3.8%, at $11.64.ETFMG Alternative Harvest(MJ), a cannabis-focused exchange-traded fund, was up 4.4%, while the S&P 500 was up 1.1%.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":361451524,"gmtCreate":1614257006868,"gmtModify":1634550443090,"author":{"id":"3573632654965791","authorId":"3573632654965791","name":"Matchapie","avatar":"https://static.tigerbbs.com/0695b1edb7a0aee8cbc2a9874745b1e6","vip":1,"crmLevel":4,"crmLevelSwitch":0,"authorIdStr":"3573632654965791","idStr":"3573632654965791"},"htmlText":"expensive is an understatement&nbsp;","listText":"expensive is an understatement&nbsp;","text":"expensive is an understatement","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/361451524","repostId":1122955763,"repostType":2,"repost":{"id":"1122955763","pubTimestamp":1614237149,"share":"https://www.laohu8.com/m/news/1122955763?lang=&edition=full","pubTime":"2021-02-25 15:12","market":"us","language":"en","title":"This Marijuana Stock Is Now ‘Too Expensive,’ Analyst Says","url":"https://stock-news.laohu8.com/highlight/detail?id=1122955763","media":"Barrons","summary":"Canopy Growth shares were rising on Wednesday, along with its Canadian cannabis peers. An analyst at","content":"<p>Canopy Growth&nbsp;shares were rising on Wednesday, along with its Canadian cannabis peers. An analyst at Jefferies says the stock is now “too expensive.”</p>\n<p>Owen Bennett&nbsp;lowered his rating on Canopy stock (ticker: CGC) to Underperform from Hold, though he upped his price target to $23.03 from $21.10. He argues the stock’s valuation, relative to peers, is deservedly higher due to its opportunities to enter the U.S. market when it’s legal to do so. Yet he argues investors shouldn’t play U.S. legalization with the stock at these levels.</p>\n<p>As&nbsp;Barron’s&nbsp;note&nbsp;dearlier this month, popular U.S. growers includeCuraleaf Holdings(CURLF),Trulieve Cannabis(TCNNF),Green Thumb Industries(GTBIF), and&nbsp;Cresco Labs(CRLBF).</p>\n<p>Given that Canopy and the U.S. grower it has a contingent deal to acquire, Acreage Holdings, are losing money, Bennett sees other U.S. growers with superior fundamental outlooks. Meanwhile, he says, the Canadian market is still in a period of transition following industrywide missteps in the rollout of legal cannabis. While he sees some encouraging signs, he argues it is still too early to turn bullish on that market.</p>\n<p>Bennett also maintained an Underperform rating onAurora Cannabisshares (ACB) in a note on Wednesday, though he raised his price target to $7.49 from $3.58. He said the company’s second-quarter results, reported earlier this month, “only reinforced our concerns on its underlying business.”</p>\n<p>“First, Canadian sales pressures were more pronounced than we had assumed, with little improvement on the margin profile,” Bennett wrote. “Second, given the near-term debt overhang and its high cash burn rate, we raise questions marks on whether Aurora’s balance sheet is strong enough to support a potential US push.”</p>\n<p>The downgrade hasn’t scared investors away, at least not yet. Canopy stock was up 0.8%, at $35.6, in recent trading. Aurora stock was up 3.8%, at $11.64.ETFMG Alternative Harvest(MJ), a cannabis-focused exchange-traded fund, was up 4.4%, while the&nbsp;S&amp;P 500&nbsp;was up 1.1%.</p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>This Marijuana Stock Is Now ‘Too Expensive,’ Analyst Says</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThis Marijuana Stock Is Now ‘Too Expensive,’ Analyst Says\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-02-25 15:12 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.barrons.com/articles/this-cannabis-stock-is-now-too-expensive-analyst-says-51614198173?mod=hp_DAY_9><strong>Barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Canopy Growth shares were rising on Wednesday, along with its Canadian cannabis peers. An analyst at Jefferies says the stock is now “too expensive.”\nOwen Bennett lowered his rating on Canopy stock (...</p>\n\n<a href=\"https://www.barrons.com/articles/this-cannabis-stock-is-now-too-expensive-analyst-says-51614198173?mod=hp_DAY_9\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CRON":"Cronos Group Inc.","CGC":"Canopy Growth Corporation","MJ":"Amplify Alternative Harvest ETF","ACB":"奥罗拉大麻公司","APHA":"Aphria Inc.","SNDL":"SNDL Inc."},"source_url":"https://www.barrons.com/articles/this-cannabis-stock-is-now-too-expensive-analyst-says-51614198173?mod=hp_DAY_9","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1122955763","content_text":"Canopy Growth shares were rising on Wednesday, along with its Canadian cannabis peers. An analyst at Jefferies says the stock is now “too expensive.”\nOwen Bennett lowered his rating on Canopy stock (ticker: CGC) to Underperform from Hold, though he upped his price target to $23.03 from $21.10. He argues the stock’s valuation, relative to peers, is deservedly higher due to its opportunities to enter the U.S. market when it’s legal to do so. Yet he argues investors shouldn’t play U.S. legalization with the stock at these levels.\nAs Barron’s note dearlier this month, popular U.S. growers includeCuraleaf Holdings(CURLF),Trulieve Cannabis(TCNNF),Green Thumb Industries(GTBIF), and Cresco Labs(CRLBF).\nGiven that Canopy and the U.S. grower it has a contingent deal to acquire, Acreage Holdings, are losing money, Bennett sees other U.S. growers with superior fundamental outlooks. Meanwhile, he says, the Canadian market is still in a period of transition following industrywide missteps in the rollout of legal cannabis. While he sees some encouraging signs, he argues it is still too early to turn bullish on that market.\nBennett also maintained an Underperform rating onAurora Cannabisshares (ACB) in a note on Wednesday, though he raised his price target to $7.49 from $3.58. He said the company’s second-quarter results, reported earlier this month, “only reinforced our concerns on its underlying business.”\n“First, Canadian sales pressures were more pronounced than we had assumed, with little improvement on the margin profile,” Bennett wrote. “Second, given the near-term debt overhang and its high cash burn rate, we raise questions marks on whether Aurora’s balance sheet is strong enough to support a potential US push.”\nThe downgrade hasn’t scared investors away, at least not yet. Canopy stock was up 0.8%, at $35.6, in recent trading. Aurora stock was up 3.8%, at $11.64.ETFMG Alternative Harvest(MJ), a cannabis-focused exchange-traded fund, was up 4.4%, while the S&P 500 was up 1.1%.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":361433487,"gmtCreate":1614252722649,"gmtModify":1634550464942,"author":{"id":"3574212983712096","authorId":"3574212983712096","name":"spin37gy","avatar":"https://static.tigerbbs.com/97dfcecfb7a4ab4bcb3c2ae6bb551e51","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3574212983712096","idStr":"3574212983712096"},"htmlText":"Its not too expensive because i bought it at high price.. 😭","listText":"Its not too expensive because i bought it at high price.. 😭","text":"Its not too expensive because i bought it at high price.. 😭","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/361433487","repostId":1122955763,"repostType":2,"repost":{"id":"1122955763","pubTimestamp":1614237149,"share":"https://www.laohu8.com/m/news/1122955763?lang=&edition=full","pubTime":"2021-02-25 15:12","market":"us","language":"en","title":"This Marijuana Stock Is Now ‘Too Expensive,’ Analyst Says","url":"https://stock-news.laohu8.com/highlight/detail?id=1122955763","media":"Barrons","summary":"Canopy Growth shares were rising on Wednesday, along with its Canadian cannabis peers. An analyst at","content":"<p>Canopy Growth&nbsp;shares were rising on Wednesday, along with its Canadian cannabis peers. An analyst at Jefferies says the stock is now “too expensive.”</p>\n<p>Owen Bennett&nbsp;lowered his rating on Canopy stock (ticker: CGC) to Underperform from Hold, though he upped his price target to $23.03 from $21.10. He argues the stock’s valuation, relative to peers, is deservedly higher due to its opportunities to enter the U.S. market when it’s legal to do so. Yet he argues investors shouldn’t play U.S. legalization with the stock at these levels.</p>\n<p>As&nbsp;Barron’s&nbsp;note&nbsp;dearlier this month, popular U.S. growers includeCuraleaf Holdings(CURLF),Trulieve Cannabis(TCNNF),Green Thumb Industries(GTBIF), and&nbsp;Cresco Labs(CRLBF).</p>\n<p>Given that Canopy and the U.S. grower it has a contingent deal to acquire, Acreage Holdings, are losing money, Bennett sees other U.S. growers with superior fundamental outlooks. Meanwhile, he says, the Canadian market is still in a period of transition following industrywide missteps in the rollout of legal cannabis. While he sees some encouraging signs, he argues it is still too early to turn bullish on that market.</p>\n<p>Bennett also maintained an Underperform rating onAurora Cannabisshares (ACB) in a note on Wednesday, though he raised his price target to $7.49 from $3.58. He said the company’s second-quarter results, reported earlier this month, “only reinforced our concerns on its underlying business.”</p>\n<p>“First, Canadian sales pressures were more pronounced than we had assumed, with little improvement on the margin profile,” Bennett wrote. “Second, given the near-term debt overhang and its high cash burn rate, we raise questions marks on whether Aurora’s balance sheet is strong enough to support a potential US push.”</p>\n<p>The downgrade hasn’t scared investors away, at least not yet. Canopy stock was up 0.8%, at $35.6, in recent trading. Aurora stock was up 3.8%, at $11.64.ETFMG Alternative Harvest(MJ), a cannabis-focused exchange-traded fund, was up 4.4%, while the&nbsp;S&amp;P 500&nbsp;was up 1.1%.</p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>This Marijuana Stock Is Now ‘Too Expensive,’ Analyst Says</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThis Marijuana Stock Is Now ‘Too Expensive,’ Analyst Says\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-02-25 15:12 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.barrons.com/articles/this-cannabis-stock-is-now-too-expensive-analyst-says-51614198173?mod=hp_DAY_9><strong>Barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Canopy Growth shares were rising on Wednesday, along with its Canadian cannabis peers. An analyst at Jefferies says the stock is now “too expensive.”\nOwen Bennett lowered his rating on Canopy stock (...</p>\n\n<a href=\"https://www.barrons.com/articles/this-cannabis-stock-is-now-too-expensive-analyst-says-51614198173?mod=hp_DAY_9\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CRON":"Cronos Group Inc.","CGC":"Canopy Growth Corporation","MJ":"Amplify Alternative Harvest ETF","ACB":"奥罗拉大麻公司","APHA":"Aphria Inc.","SNDL":"SNDL Inc."},"source_url":"https://www.barrons.com/articles/this-cannabis-stock-is-now-too-expensive-analyst-says-51614198173?mod=hp_DAY_9","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1122955763","content_text":"Canopy Growth shares were rising on Wednesday, along with its Canadian cannabis peers. An analyst at Jefferies says the stock is now “too expensive.”\nOwen Bennett lowered his rating on Canopy stock (ticker: CGC) to Underperform from Hold, though he upped his price target to $23.03 from $21.10. He argues the stock’s valuation, relative to peers, is deservedly higher due to its opportunities to enter the U.S. market when it’s legal to do so. Yet he argues investors shouldn’t play U.S. legalization with the stock at these levels.\nAs Barron’s note dearlier this month, popular U.S. growers includeCuraleaf Holdings(CURLF),Trulieve Cannabis(TCNNF),Green Thumb Industries(GTBIF), and Cresco Labs(CRLBF).\nGiven that Canopy and the U.S. grower it has a contingent deal to acquire, Acreage Holdings, are losing money, Bennett sees other U.S. growers with superior fundamental outlooks. Meanwhile, he says, the Canadian market is still in a period of transition following industrywide missteps in the rollout of legal cannabis. While he sees some encouraging signs, he argues it is still too early to turn bullish on that market.\nBennett also maintained an Underperform rating onAurora Cannabisshares (ACB) in a note on Wednesday, though he raised his price target to $7.49 from $3.58. He said the company’s second-quarter results, reported earlier this month, “only reinforced our concerns on its underlying business.”\n“First, Canadian sales pressures were more pronounced than we had assumed, with little improvement on the margin profile,” Bennett wrote. “Second, given the near-term debt overhang and its high cash burn rate, we raise questions marks on whether Aurora’s balance sheet is strong enough to support a potential US push.”\nThe downgrade hasn’t scared investors away, at least not yet. Canopy stock was up 0.8%, at $35.6, in recent trading. Aurora stock was up 3.8%, at $11.64.ETFMG Alternative Harvest(MJ), a cannabis-focused exchange-traded fund, was up 4.4%, while the S&P 500 was up 1.1%.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":361495365,"gmtCreate":1614252167157,"gmtModify":1634550467381,"author":{"id":"3558920222538997","authorId":"3558920222538997","name":"不是那么好割的小韭菜","avatar":"https://static.tigerbbs.com/904e087829710bbff7692246e238149c","vip":1,"crmLevel":3,"crmLevelSwitch":0,"authorIdStr":"3558920222538997","idStr":"3558920222538997"},"htmlText":"Bullshit","listText":"Bullshit","text":"Bullshit","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/361495365","repostId":1122955763,"repostType":4,"repost":{"id":"1122955763","pubTimestamp":1614237149,"share":"https://www.laohu8.com/m/news/1122955763?lang=&edition=full","pubTime":"2021-02-25 15:12","market":"us","language":"en","title":"This Marijuana Stock Is Now ‘Too Expensive,’ Analyst Says","url":"https://stock-news.laohu8.com/highlight/detail?id=1122955763","media":"Barrons","summary":"Canopy Growth shares were rising on Wednesday, along with its Canadian cannabis peers. An analyst at","content":"<p>Canopy Growth&nbsp;shares were rising on Wednesday, along with its Canadian cannabis peers. An analyst at Jefferies says the stock is now “too expensive.”</p>\n<p>Owen Bennett&nbsp;lowered his rating on Canopy stock (ticker: CGC) to Underperform from Hold, though he upped his price target to $23.03 from $21.10. He argues the stock’s valuation, relative to peers, is deservedly higher due to its opportunities to enter the U.S. market when it’s legal to do so. Yet he argues investors shouldn’t play U.S. legalization with the stock at these levels.</p>\n<p>As&nbsp;Barron’s&nbsp;note&nbsp;dearlier this month, popular U.S. growers includeCuraleaf Holdings(CURLF),Trulieve Cannabis(TCNNF),Green Thumb Industries(GTBIF), and&nbsp;Cresco Labs(CRLBF).</p>\n<p>Given that Canopy and the U.S. grower it has a contingent deal to acquire, Acreage Holdings, are losing money, Bennett sees other U.S. growers with superior fundamental outlooks. Meanwhile, he says, the Canadian market is still in a period of transition following industrywide missteps in the rollout of legal cannabis. While he sees some encouraging signs, he argues it is still too early to turn bullish on that market.</p>\n<p>Bennett also maintained an Underperform rating onAurora Cannabisshares (ACB) in a note on Wednesday, though he raised his price target to $7.49 from $3.58. He said the company’s second-quarter results, reported earlier this month, “only reinforced our concerns on its underlying business.”</p>\n<p>“First, Canadian sales pressures were more pronounced than we had assumed, with little improvement on the margin profile,” Bennett wrote. “Second, given the near-term debt overhang and its high cash burn rate, we raise questions marks on whether Aurora’s balance sheet is strong enough to support a potential US push.”</p>\n<p>The downgrade hasn’t scared investors away, at least not yet. Canopy stock was up 0.8%, at $35.6, in recent trading. Aurora stock was up 3.8%, at $11.64.ETFMG Alternative Harvest(MJ), a cannabis-focused exchange-traded fund, was up 4.4%, while the&nbsp;S&amp;P 500&nbsp;was up 1.1%.</p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>This Marijuana Stock Is Now ‘Too Expensive,’ Analyst Says</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThis Marijuana Stock Is Now ‘Too Expensive,’ Analyst Says\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-02-25 15:12 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.barrons.com/articles/this-cannabis-stock-is-now-too-expensive-analyst-says-51614198173?mod=hp_DAY_9><strong>Barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Canopy Growth shares were rising on Wednesday, along with its Canadian cannabis peers. An analyst at Jefferies says the stock is now “too expensive.”\nOwen Bennett lowered his rating on Canopy stock (...</p>\n\n<a href=\"https://www.barrons.com/articles/this-cannabis-stock-is-now-too-expensive-analyst-says-51614198173?mod=hp_DAY_9\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CRON":"Cronos Group Inc.","CGC":"Canopy Growth Corporation","MJ":"Amplify Alternative Harvest ETF","ACB":"奥罗拉大麻公司","APHA":"Aphria Inc.","SNDL":"SNDL Inc."},"source_url":"https://www.barrons.com/articles/this-cannabis-stock-is-now-too-expensive-analyst-says-51614198173?mod=hp_DAY_9","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1122955763","content_text":"Canopy Growth shares were rising on Wednesday, along with its Canadian cannabis peers. An analyst at Jefferies says the stock is now “too expensive.”\nOwen Bennett lowered his rating on Canopy stock (ticker: CGC) to Underperform from Hold, though he upped his price target to $23.03 from $21.10. He argues the stock’s valuation, relative to peers, is deservedly higher due to its opportunities to enter the U.S. market when it’s legal to do so. Yet he argues investors shouldn’t play U.S. legalization with the stock at these levels.\nAs Barron’s note dearlier this month, popular U.S. growers includeCuraleaf Holdings(CURLF),Trulieve Cannabis(TCNNF),Green Thumb Industries(GTBIF), and Cresco Labs(CRLBF).\nGiven that Canopy and the U.S. grower it has a contingent deal to acquire, Acreage Holdings, are losing money, Bennett sees other U.S. growers with superior fundamental outlooks. Meanwhile, he says, the Canadian market is still in a period of transition following industrywide missteps in the rollout of legal cannabis. While he sees some encouraging signs, he argues it is still too early to turn bullish on that market.\nBennett also maintained an Underperform rating onAurora Cannabisshares (ACB) in a note on Wednesday, though he raised his price target to $7.49 from $3.58. He said the company’s second-quarter results, reported earlier this month, “only reinforced our concerns on its underlying business.”\n“First, Canadian sales pressures were more pronounced than we had assumed, with little improvement on the margin profile,” Bennett wrote. “Second, given the near-term debt overhang and its high cash burn rate, we raise questions marks on whether Aurora’s balance sheet is strong enough to support a potential US push.”\nThe downgrade hasn’t scared investors away, at least not yet. Canopy stock was up 0.8%, at $35.6, in recent trading. Aurora stock was up 3.8%, at $11.64.ETFMG Alternative Harvest(MJ), a cannabis-focused exchange-traded fund, was up 4.4%, while the S&P 500 was up 1.1%.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":361551049,"gmtCreate":1614248634381,"gmtModify":1634550491224,"author":{"id":"3570959810686312","authorId":"3570959810686312","name":"Mageswari","avatar":"https://static.tigerbbs.com/e0ce3bc82e7c0927ef52a87eb74c6225","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3570959810686312","idStr":"3570959810686312"},"htmlText":"Hmmmmm","listText":"Hmmmmm","text":"Hmmmmm","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/361551049","repostId":1122955763,"repostType":4,"repost":{"id":"1122955763","pubTimestamp":1614237149,"share":"https://www.laohu8.com/m/news/1122955763?lang=&edition=full","pubTime":"2021-02-25 15:12","market":"us","language":"en","title":"This Marijuana Stock Is Now ‘Too Expensive,’ Analyst Says","url":"https://stock-news.laohu8.com/highlight/detail?id=1122955763","media":"Barrons","summary":"Canopy Growth shares were rising on Wednesday, along with its Canadian cannabis peers. An analyst at","content":"<p>Canopy Growth&nbsp;shares were rising on Wednesday, along with its Canadian cannabis peers. An analyst at Jefferies says the stock is now “too expensive.”</p>\n<p>Owen Bennett&nbsp;lowered his rating on Canopy stock (ticker: CGC) to Underperform from Hold, though he upped his price target to $23.03 from $21.10. He argues the stock’s valuation, relative to peers, is deservedly higher due to its opportunities to enter the U.S. market when it’s legal to do so. Yet he argues investors shouldn’t play U.S. legalization with the stock at these levels.</p>\n<p>As&nbsp;Barron’s&nbsp;note&nbsp;dearlier this month, popular U.S. growers includeCuraleaf Holdings(CURLF),Trulieve Cannabis(TCNNF),Green Thumb Industries(GTBIF), and&nbsp;Cresco Labs(CRLBF).</p>\n<p>Given that Canopy and the U.S. grower it has a contingent deal to acquire, Acreage Holdings, are losing money, Bennett sees other U.S. growers with superior fundamental outlooks. Meanwhile, he says, the Canadian market is still in a period of transition following industrywide missteps in the rollout of legal cannabis. While he sees some encouraging signs, he argues it is still too early to turn bullish on that market.</p>\n<p>Bennett also maintained an Underperform rating onAurora Cannabisshares (ACB) in a note on Wednesday, though he raised his price target to $7.49 from $3.58. He said the company’s second-quarter results, reported earlier this month, “only reinforced our concerns on its underlying business.”</p>\n<p>“First, Canadian sales pressures were more pronounced than we had assumed, with little improvement on the margin profile,” Bennett wrote. “Second, given the near-term debt overhang and its high cash burn rate, we raise questions marks on whether Aurora’s balance sheet is strong enough to support a potential US push.”</p>\n<p>The downgrade hasn’t scared investors away, at least not yet. Canopy stock was up 0.8%, at $35.6, in recent trading. Aurora stock was up 3.8%, at $11.64.ETFMG Alternative Harvest(MJ), a cannabis-focused exchange-traded fund, was up 4.4%, while the&nbsp;S&amp;P 500&nbsp;was up 1.1%.</p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>This Marijuana Stock Is Now ‘Too Expensive,’ Analyst Says</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThis Marijuana Stock Is Now ‘Too Expensive,’ Analyst Says\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-02-25 15:12 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.barrons.com/articles/this-cannabis-stock-is-now-too-expensive-analyst-says-51614198173?mod=hp_DAY_9><strong>Barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Canopy Growth shares were rising on Wednesday, along with its Canadian cannabis peers. An analyst at Jefferies says the stock is now “too expensive.”\nOwen Bennett lowered his rating on Canopy stock (...</p>\n\n<a href=\"https://www.barrons.com/articles/this-cannabis-stock-is-now-too-expensive-analyst-says-51614198173?mod=hp_DAY_9\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CRON":"Cronos Group Inc.","CGC":"Canopy Growth Corporation","MJ":"Amplify Alternative Harvest ETF","ACB":"奥罗拉大麻公司","APHA":"Aphria Inc.","SNDL":"SNDL Inc."},"source_url":"https://www.barrons.com/articles/this-cannabis-stock-is-now-too-expensive-analyst-says-51614198173?mod=hp_DAY_9","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1122955763","content_text":"Canopy Growth shares were rising on Wednesday, along with its Canadian cannabis peers. An analyst at Jefferies says the stock is now “too expensive.”\nOwen Bennett lowered his rating on Canopy stock (ticker: CGC) to Underperform from Hold, though he upped his price target to $23.03 from $21.10. He argues the stock’s valuation, relative to peers, is deservedly higher due to its opportunities to enter the U.S. market when it’s legal to do so. Yet he argues investors shouldn’t play U.S. legalization with the stock at these levels.\nAs Barron’s note dearlier this month, popular U.S. growers includeCuraleaf Holdings(CURLF),Trulieve Cannabis(TCNNF),Green Thumb Industries(GTBIF), and Cresco Labs(CRLBF).\nGiven that Canopy and the U.S. grower it has a contingent deal to acquire, Acreage Holdings, are losing money, Bennett sees other U.S. growers with superior fundamental outlooks. Meanwhile, he says, the Canadian market is still in a period of transition following industrywide missteps in the rollout of legal cannabis. While he sees some encouraging signs, he argues it is still too early to turn bullish on that market.\nBennett also maintained an Underperform rating onAurora Cannabisshares (ACB) in a note on Wednesday, though he raised his price target to $7.49 from $3.58. He said the company’s second-quarter results, reported earlier this month, “only reinforced our concerns on its underlying business.”\n“First, Canadian sales pressures were more pronounced than we had assumed, with little improvement on the margin profile,” Bennett wrote. “Second, given the near-term debt overhang and its high cash burn rate, we raise questions marks on whether Aurora’s balance sheet is strong enough to support a potential US push.”\nThe downgrade hasn’t scared investors away, at least not yet. Canopy stock was up 0.8%, at $35.6, in recent trading. Aurora stock was up 3.8%, at $11.64.ETFMG Alternative Harvest(MJ), a cannabis-focused exchange-traded fund, was up 4.4%, while the S&P 500 was up 1.1%.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":361503974,"gmtCreate":1614244056898,"gmtModify":1634550518641,"author":{"id":"3573791132602647","authorId":"3573791132602647","name":"JJ88","avatar":"https://static.tigerbbs.com/b66b76318e003dd981bfaf5b6540d311","vip":1,"crmLevel":1,"crmLevelSwitch":0,"authorIdStr":"3573791132602647","idStr":"3573791132602647"},"htmlText":"😮","listText":"😮","text":"😮","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/361503974","repostId":1122955763,"repostType":4,"repost":{"id":"1122955763","pubTimestamp":1614237149,"share":"https://www.laohu8.com/m/news/1122955763?lang=&edition=full","pubTime":"2021-02-25 15:12","market":"us","language":"en","title":"This Marijuana Stock Is Now ‘Too Expensive,’ Analyst Says","url":"https://stock-news.laohu8.com/highlight/detail?id=1122955763","media":"Barrons","summary":"Canopy Growth shares were rising on Wednesday, along with its Canadian cannabis peers. An analyst at","content":"<p>Canopy Growth&nbsp;shares were rising on Wednesday, along with its Canadian cannabis peers. An analyst at Jefferies says the stock is now “too expensive.”</p>\n<p>Owen Bennett&nbsp;lowered his rating on Canopy stock (ticker: CGC) to Underperform from Hold, though he upped his price target to $23.03 from $21.10. He argues the stock’s valuation, relative to peers, is deservedly higher due to its opportunities to enter the U.S. market when it’s legal to do so. Yet he argues investors shouldn’t play U.S. legalization with the stock at these levels.</p>\n<p>As&nbsp;Barron’s&nbsp;note&nbsp;dearlier this month, popular U.S. growers includeCuraleaf Holdings(CURLF),Trulieve Cannabis(TCNNF),Green Thumb Industries(GTBIF), and&nbsp;Cresco Labs(CRLBF).</p>\n<p>Given that Canopy and the U.S. grower it has a contingent deal to acquire, Acreage Holdings, are losing money, Bennett sees other U.S. growers with superior fundamental outlooks. Meanwhile, he says, the Canadian market is still in a period of transition following industrywide missteps in the rollout of legal cannabis. While he sees some encouraging signs, he argues it is still too early to turn bullish on that market.</p>\n<p>Bennett also maintained an Underperform rating onAurora Cannabisshares (ACB) in a note on Wednesday, though he raised his price target to $7.49 from $3.58. He said the company’s second-quarter results, reported earlier this month, “only reinforced our concerns on its underlying business.”</p>\n<p>“First, Canadian sales pressures were more pronounced than we had assumed, with little improvement on the margin profile,” Bennett wrote. “Second, given the near-term debt overhang and its high cash burn rate, we raise questions marks on whether Aurora’s balance sheet is strong enough to support a potential US push.”</p>\n<p>The downgrade hasn’t scared investors away, at least not yet. Canopy stock was up 0.8%, at $35.6, in recent trading. Aurora stock was up 3.8%, at $11.64.ETFMG Alternative Harvest(MJ), a cannabis-focused exchange-traded fund, was up 4.4%, while the&nbsp;S&amp;P 500&nbsp;was up 1.1%.</p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>This Marijuana Stock Is Now ‘Too Expensive,’ Analyst Says</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThis Marijuana Stock Is Now ‘Too Expensive,’ Analyst Says\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-02-25 15:12 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.barrons.com/articles/this-cannabis-stock-is-now-too-expensive-analyst-says-51614198173?mod=hp_DAY_9><strong>Barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Canopy Growth shares were rising on Wednesday, along with its Canadian cannabis peers. An analyst at Jefferies says the stock is now “too expensive.”\nOwen Bennett lowered his rating on Canopy stock (...</p>\n\n<a href=\"https://www.barrons.com/articles/this-cannabis-stock-is-now-too-expensive-analyst-says-51614198173?mod=hp_DAY_9\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CRON":"Cronos Group Inc.","CGC":"Canopy Growth Corporation","MJ":"Amplify Alternative Harvest ETF","ACB":"奥罗拉大麻公司","APHA":"Aphria Inc.","SNDL":"SNDL Inc."},"source_url":"https://www.barrons.com/articles/this-cannabis-stock-is-now-too-expensive-analyst-says-51614198173?mod=hp_DAY_9","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1122955763","content_text":"Canopy Growth shares were rising on Wednesday, along with its Canadian cannabis peers. An analyst at Jefferies says the stock is now “too expensive.”\nOwen Bennett lowered his rating on Canopy stock (ticker: CGC) to Underperform from Hold, though he upped his price target to $23.03 from $21.10. He argues the stock’s valuation, relative to peers, is deservedly higher due to its opportunities to enter the U.S. market when it’s legal to do so. Yet he argues investors shouldn’t play U.S. legalization with the stock at these levels.\nAs Barron’s note dearlier this month, popular U.S. growers includeCuraleaf Holdings(CURLF),Trulieve Cannabis(TCNNF),Green Thumb Industries(GTBIF), and Cresco Labs(CRLBF).\nGiven that Canopy and the U.S. grower it has a contingent deal to acquire, Acreage Holdings, are losing money, Bennett sees other U.S. growers with superior fundamental outlooks. Meanwhile, he says, the Canadian market is still in a period of transition following industrywide missteps in the rollout of legal cannabis. While he sees some encouraging signs, he argues it is still too early to turn bullish on that market.\nBennett also maintained an Underperform rating onAurora Cannabisshares (ACB) in a note on Wednesday, though he raised his price target to $7.49 from $3.58. He said the company’s second-quarter results, reported earlier this month, “only reinforced our concerns on its underlying business.”\n“First, Canadian sales pressures were more pronounced than we had assumed, with little improvement on the margin profile,” Bennett wrote. “Second, given the near-term debt overhang and its high cash burn rate, we raise questions marks on whether Aurora’s balance sheet is strong enough to support a potential US push.”\nThe downgrade hasn’t scared investors away, at least not yet. Canopy stock was up 0.8%, at $35.6, in recent trading. Aurora stock was up 3.8%, at $11.64.ETFMG Alternative Harvest(MJ), a cannabis-focused exchange-traded fund, was up 4.4%, while the S&P 500 was up 1.1%.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":361228940,"gmtCreate":1614240985180,"gmtModify":1634550530774,"author":{"id":"3575011341539105","authorId":"3575011341539105","name":"kuppi","avatar":"https://static.tigerbbs.com/1a1c96e4fc6f6f67de0450751c853214","vip":1,"crmLevel":3,"crmLevelSwitch":0,"authorIdStr":"3575011341539105","idStr":"3575011341539105"},"htmlText":"There are penny stocks available also.SNDL seems to be a good deal","listText":"There are penny stocks available also.SNDL seems to be a good deal","text":"There are penny stocks available also.SNDL seems to be a good deal","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/361228940","repostId":1122955763,"repostType":4,"repost":{"id":"1122955763","pubTimestamp":1614237149,"share":"https://www.laohu8.com/m/news/1122955763?lang=&edition=full","pubTime":"2021-02-25 15:12","market":"us","language":"en","title":"This Marijuana Stock Is Now ‘Too Expensive,’ Analyst Says","url":"https://stock-news.laohu8.com/highlight/detail?id=1122955763","media":"Barrons","summary":"Canopy Growth shares were rising on Wednesday, along with its Canadian cannabis peers. An analyst at","content":"<p>Canopy Growth&nbsp;shares were rising on Wednesday, along with its Canadian cannabis peers. An analyst at Jefferies says the stock is now “too expensive.”</p>\n<p>Owen Bennett&nbsp;lowered his rating on Canopy stock (ticker: CGC) to Underperform from Hold, though he upped his price target to $23.03 from $21.10. He argues the stock’s valuation, relative to peers, is deservedly higher due to its opportunities to enter the U.S. market when it’s legal to do so. Yet he argues investors shouldn’t play U.S. legalization with the stock at these levels.</p>\n<p>As&nbsp;Barron’s&nbsp;note&nbsp;dearlier this month, popular U.S. growers includeCuraleaf Holdings(CURLF),Trulieve Cannabis(TCNNF),Green Thumb Industries(GTBIF), and&nbsp;Cresco Labs(CRLBF).</p>\n<p>Given that Canopy and the U.S. grower it has a contingent deal to acquire, Acreage Holdings, are losing money, Bennett sees other U.S. growers with superior fundamental outlooks. Meanwhile, he says, the Canadian market is still in a period of transition following industrywide missteps in the rollout of legal cannabis. While he sees some encouraging signs, he argues it is still too early to turn bullish on that market.</p>\n<p>Bennett also maintained an Underperform rating onAurora Cannabisshares (ACB) in a note on Wednesday, though he raised his price target to $7.49 from $3.58. He said the company’s second-quarter results, reported earlier this month, “only reinforced our concerns on its underlying business.”</p>\n<p>“First, Canadian sales pressures were more pronounced than we had assumed, with little improvement on the margin profile,” Bennett wrote. “Second, given the near-term debt overhang and its high cash burn rate, we raise questions marks on whether Aurora’s balance sheet is strong enough to support a potential US push.”</p>\n<p>The downgrade hasn’t scared investors away, at least not yet. Canopy stock was up 0.8%, at $35.6, in recent trading. Aurora stock was up 3.8%, at $11.64.ETFMG Alternative Harvest(MJ), a cannabis-focused exchange-traded fund, was up 4.4%, while the&nbsp;S&amp;P 500&nbsp;was up 1.1%.</p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>This Marijuana Stock Is Now ‘Too Expensive,’ Analyst Says</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThis Marijuana Stock Is Now ‘Too Expensive,’ Analyst Says\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-02-25 15:12 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.barrons.com/articles/this-cannabis-stock-is-now-too-expensive-analyst-says-51614198173?mod=hp_DAY_9><strong>Barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Canopy Growth shares were rising on Wednesday, along with its Canadian cannabis peers. An analyst at Jefferies says the stock is now “too expensive.”\nOwen Bennett lowered his rating on Canopy stock (...</p>\n\n<a href=\"https://www.barrons.com/articles/this-cannabis-stock-is-now-too-expensive-analyst-says-51614198173?mod=hp_DAY_9\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CRON":"Cronos Group Inc.","CGC":"Canopy Growth Corporation","MJ":"Amplify Alternative Harvest ETF","ACB":"奥罗拉大麻公司","APHA":"Aphria Inc.","SNDL":"SNDL Inc."},"source_url":"https://www.barrons.com/articles/this-cannabis-stock-is-now-too-expensive-analyst-says-51614198173?mod=hp_DAY_9","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1122955763","content_text":"Canopy Growth shares were rising on Wednesday, along with its Canadian cannabis peers. An analyst at Jefferies says the stock is now “too expensive.”\nOwen Bennett lowered his rating on Canopy stock (ticker: CGC) to Underperform from Hold, though he upped his price target to $23.03 from $21.10. He argues the stock’s valuation, relative to peers, is deservedly higher due to its opportunities to enter the U.S. market when it’s legal to do so. Yet he argues investors shouldn’t play U.S. legalization with the stock at these levels.\nAs Barron’s note dearlier this month, popular U.S. growers includeCuraleaf Holdings(CURLF),Trulieve Cannabis(TCNNF),Green Thumb Industries(GTBIF), and Cresco Labs(CRLBF).\nGiven that Canopy and the U.S. grower it has a contingent deal to acquire, Acreage Holdings, are losing money, Bennett sees other U.S. growers with superior fundamental outlooks. Meanwhile, he says, the Canadian market is still in a period of transition following industrywide missteps in the rollout of legal cannabis. While he sees some encouraging signs, he argues it is still too early to turn bullish on that market.\nBennett also maintained an Underperform rating onAurora Cannabisshares (ACB) in a note on Wednesday, though he raised his price target to $7.49 from $3.58. He said the company’s second-quarter results, reported earlier this month, “only reinforced our concerns on its underlying business.”\n“First, Canadian sales pressures were more pronounced than we had assumed, with little improvement on the margin profile,” Bennett wrote. “Second, given the near-term debt overhang and its high cash burn rate, we raise questions marks on whether Aurora’s balance sheet is strong enough to support a potential US push.”\nThe downgrade hasn’t scared investors away, at least not yet. Canopy stock was up 0.8%, at $35.6, in recent trading. Aurora stock was up 3.8%, at $11.64.ETFMG Alternative Harvest(MJ), a cannabis-focused exchange-traded fund, was up 4.4%, while the S&P 500 was up 1.1%.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":3659602,"gmtCreate":1614246289049,"gmtModify":1635761222849,"authorId":3568205918507543,"author":{"id":3568205918507543,"idStr":"3568205918507543","authorId":3568205918507543,"name":"dawnyong","avatar":"https://static.tigerbbs.com/4dc32f94211c2b67550a75832319e35a","vip":1,"crmLevel":8,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":361228940,"type":1,"supId":0,"prevId":0,"content":"Tt","text":"Tt","html":"Tt"}],"langContent":"EN"},{"id":361261010,"gmtCreate":1614239899630,"gmtModify":1634550534171,"author":{"id":"3575517086746478","authorId":"3575517086746478","name":"CherilynC","avatar":"https://static.tigerbbs.com/9e05056a8c74c7cf8e845972d63e5b34","vip":1,"crmLevel":4,"crmLevelSwitch":0,"authorIdStr":"3575517086746478","idStr":"3575517086746478"},"htmlText":"It’s never too expensive","listText":"It’s never too expensive","text":"It’s never too expensive","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/361261010","repostId":1122955763,"repostType":4,"repost":{"id":"1122955763","pubTimestamp":1614237149,"share":"https://www.laohu8.com/m/news/1122955763?lang=&edition=full","pubTime":"2021-02-25 15:12","market":"us","language":"en","title":"This Marijuana Stock Is Now ‘Too Expensive,’ Analyst Says","url":"https://stock-news.laohu8.com/highlight/detail?id=1122955763","media":"Barrons","summary":"Canopy Growth shares were rising on Wednesday, along with its Canadian cannabis peers. An analyst at","content":"<p>Canopy Growth&nbsp;shares were rising on Wednesday, along with its Canadian cannabis peers. An analyst at Jefferies says the stock is now “too expensive.”</p>\n<p>Owen Bennett&nbsp;lowered his rating on Canopy stock (ticker: CGC) to Underperform from Hold, though he upped his price target to $23.03 from $21.10. He argues the stock’s valuation, relative to peers, is deservedly higher due to its opportunities to enter the U.S. market when it’s legal to do so. Yet he argues investors shouldn’t play U.S. legalization with the stock at these levels.</p>\n<p>As&nbsp;Barron’s&nbsp;note&nbsp;dearlier this month, popular U.S. growers includeCuraleaf Holdings(CURLF),Trulieve Cannabis(TCNNF),Green Thumb Industries(GTBIF), and&nbsp;Cresco Labs(CRLBF).</p>\n<p>Given that Canopy and the U.S. grower it has a contingent deal to acquire, Acreage Holdings, are losing money, Bennett sees other U.S. growers with superior fundamental outlooks. Meanwhile, he says, the Canadian market is still in a period of transition following industrywide missteps in the rollout of legal cannabis. While he sees some encouraging signs, he argues it is still too early to turn bullish on that market.</p>\n<p>Bennett also maintained an Underperform rating onAurora Cannabisshares (ACB) in a note on Wednesday, though he raised his price target to $7.49 from $3.58. He said the company’s second-quarter results, reported earlier this month, “only reinforced our concerns on its underlying business.”</p>\n<p>“First, Canadian sales pressures were more pronounced than we had assumed, with little improvement on the margin profile,” Bennett wrote. “Second, given the near-term debt overhang and its high cash burn rate, we raise questions marks on whether Aurora’s balance sheet is strong enough to support a potential US push.”</p>\n<p>The downgrade hasn’t scared investors away, at least not yet. Canopy stock was up 0.8%, at $35.6, in recent trading. Aurora stock was up 3.8%, at $11.64.ETFMG Alternative Harvest(MJ), a cannabis-focused exchange-traded fund, was up 4.4%, while the&nbsp;S&amp;P 500&nbsp;was up 1.1%.</p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>This Marijuana Stock Is Now ‘Too Expensive,’ Analyst Says</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThis Marijuana Stock Is Now ‘Too Expensive,’ Analyst Says\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-02-25 15:12 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.barrons.com/articles/this-cannabis-stock-is-now-too-expensive-analyst-says-51614198173?mod=hp_DAY_9><strong>Barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Canopy Growth shares were rising on Wednesday, along with its Canadian cannabis peers. An analyst at Jefferies says the stock is now “too expensive.”\nOwen Bennett lowered his rating on Canopy stock (...</p>\n\n<a href=\"https://www.barrons.com/articles/this-cannabis-stock-is-now-too-expensive-analyst-says-51614198173?mod=hp_DAY_9\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CRON":"Cronos Group Inc.","CGC":"Canopy Growth Corporation","MJ":"Amplify Alternative Harvest ETF","ACB":"奥罗拉大麻公司","APHA":"Aphria Inc.","SNDL":"SNDL Inc."},"source_url":"https://www.barrons.com/articles/this-cannabis-stock-is-now-too-expensive-analyst-says-51614198173?mod=hp_DAY_9","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1122955763","content_text":"Canopy Growth shares were rising on Wednesday, along with its Canadian cannabis peers. An analyst at Jefferies says the stock is now “too expensive.”\nOwen Bennett lowered his rating on Canopy stock (ticker: CGC) to Underperform from Hold, though he upped his price target to $23.03 from $21.10. He argues the stock’s valuation, relative to peers, is deservedly higher due to its opportunities to enter the U.S. market when it’s legal to do so. Yet he argues investors shouldn’t play U.S. legalization with the stock at these levels.\nAs Barron’s note dearlier this month, popular U.S. growers includeCuraleaf Holdings(CURLF),Trulieve Cannabis(TCNNF),Green Thumb Industries(GTBIF), and Cresco Labs(CRLBF).\nGiven that Canopy and the U.S. grower it has a contingent deal to acquire, Acreage Holdings, are losing money, Bennett sees other U.S. growers with superior fundamental outlooks. Meanwhile, he says, the Canadian market is still in a period of transition following industrywide missteps in the rollout of legal cannabis. While he sees some encouraging signs, he argues it is still too early to turn bullish on that market.\nBennett also maintained an Underperform rating onAurora Cannabisshares (ACB) in a note on Wednesday, though he raised his price target to $7.49 from $3.58. He said the company’s second-quarter results, reported earlier this month, “only reinforced our concerns on its underlying business.”\n“First, Canadian sales pressures were more pronounced than we had assumed, with little improvement on the margin profile,” Bennett wrote. “Second, given the near-term debt overhang and its high cash burn rate, we raise questions marks on whether Aurora’s balance sheet is strong enough to support a potential US push.”\nThe downgrade hasn’t scared investors away, at least not yet. Canopy stock was up 0.8%, at $35.6, in recent trading. Aurora stock was up 3.8%, at $11.64.ETFMG Alternative Harvest(MJ), a cannabis-focused exchange-traded fund, was up 4.4%, while the S&P 500 was up 1.1%.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":361284645,"gmtCreate":1614239519087,"gmtModify":1634550536635,"author":{"id":"3554966404999750","authorId":"3554966404999750","name":"WSBApes","avatar":"https://static.tigerbbs.com/524d2f8eb87bb134321ff44e82807a56","vip":1,"crmLevel":6,"crmLevelSwitch":0,"authorIdStr":"3554966404999750","idStr":"3554966404999750"},"htmlText":"Like and comment","listText":"Like and comment","text":"Like and comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/361284645","repostId":1122955763,"repostType":4,"repost":{"id":"1122955763","pubTimestamp":1614237149,"share":"https://www.laohu8.com/m/news/1122955763?lang=&edition=full","pubTime":"2021-02-25 15:12","market":"us","language":"en","title":"This Marijuana Stock Is Now ‘Too Expensive,’ Analyst Says","url":"https://stock-news.laohu8.com/highlight/detail?id=1122955763","media":"Barrons","summary":"Canopy Growth shares were rising on Wednesday, along with its Canadian cannabis peers. An analyst at","content":"<p>Canopy Growth&nbsp;shares were rising on Wednesday, along with its Canadian cannabis peers. An analyst at Jefferies says the stock is now “too expensive.”</p>\n<p>Owen Bennett&nbsp;lowered his rating on Canopy stock (ticker: CGC) to Underperform from Hold, though he upped his price target to $23.03 from $21.10. He argues the stock’s valuation, relative to peers, is deservedly higher due to its opportunities to enter the U.S. market when it’s legal to do so. Yet he argues investors shouldn’t play U.S. legalization with the stock at these levels.</p>\n<p>As&nbsp;Barron’s&nbsp;note&nbsp;dearlier this month, popular U.S. growers includeCuraleaf Holdings(CURLF),Trulieve Cannabis(TCNNF),Green Thumb Industries(GTBIF), and&nbsp;Cresco Labs(CRLBF).</p>\n<p>Given that Canopy and the U.S. grower it has a contingent deal to acquire, Acreage Holdings, are losing money, Bennett sees other U.S. growers with superior fundamental outlooks. Meanwhile, he says, the Canadian market is still in a period of transition following industrywide missteps in the rollout of legal cannabis. While he sees some encouraging signs, he argues it is still too early to turn bullish on that market.</p>\n<p>Bennett also maintained an Underperform rating onAurora Cannabisshares (ACB) in a note on Wednesday, though he raised his price target to $7.49 from $3.58. He said the company’s second-quarter results, reported earlier this month, “only reinforced our concerns on its underlying business.”</p>\n<p>“First, Canadian sales pressures were more pronounced than we had assumed, with little improvement on the margin profile,” Bennett wrote. “Second, given the near-term debt overhang and its high cash burn rate, we raise questions marks on whether Aurora’s balance sheet is strong enough to support a potential US push.”</p>\n<p>The downgrade hasn’t scared investors away, at least not yet. Canopy stock was up 0.8%, at $35.6, in recent trading. Aurora stock was up 3.8%, at $11.64.ETFMG Alternative Harvest(MJ), a cannabis-focused exchange-traded fund, was up 4.4%, while the&nbsp;S&amp;P 500&nbsp;was up 1.1%.</p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>This Marijuana Stock Is Now ‘Too Expensive,’ Analyst Says</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThis Marijuana Stock Is Now ‘Too Expensive,’ Analyst Says\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-02-25 15:12 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.barrons.com/articles/this-cannabis-stock-is-now-too-expensive-analyst-says-51614198173?mod=hp_DAY_9><strong>Barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Canopy Growth shares were rising on Wednesday, along with its Canadian cannabis peers. An analyst at Jefferies says the stock is now “too expensive.”\nOwen Bennett lowered his rating on Canopy stock (...</p>\n\n<a href=\"https://www.barrons.com/articles/this-cannabis-stock-is-now-too-expensive-analyst-says-51614198173?mod=hp_DAY_9\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CRON":"Cronos Group Inc.","CGC":"Canopy Growth Corporation","MJ":"Amplify Alternative Harvest ETF","ACB":"奥罗拉大麻公司","APHA":"Aphria Inc.","SNDL":"SNDL Inc."},"source_url":"https://www.barrons.com/articles/this-cannabis-stock-is-now-too-expensive-analyst-says-51614198173?mod=hp_DAY_9","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1122955763","content_text":"Canopy Growth shares were rising on Wednesday, along with its Canadian cannabis peers. An analyst at Jefferies says the stock is now “too expensive.”\nOwen Bennett lowered his rating on Canopy stock (ticker: CGC) to Underperform from Hold, though he upped his price target to $23.03 from $21.10. He argues the stock’s valuation, relative to peers, is deservedly higher due to its opportunities to enter the U.S. market when it’s legal to do so. Yet he argues investors shouldn’t play U.S. legalization with the stock at these levels.\nAs Barron’s note dearlier this month, popular U.S. growers includeCuraleaf Holdings(CURLF),Trulieve Cannabis(TCNNF),Green Thumb Industries(GTBIF), and Cresco Labs(CRLBF).\nGiven that Canopy and the U.S. grower it has a contingent deal to acquire, Acreage Holdings, are losing money, Bennett sees other U.S. growers with superior fundamental outlooks. Meanwhile, he says, the Canadian market is still in a period of transition following industrywide missteps in the rollout of legal cannabis. While he sees some encouraging signs, he argues it is still too early to turn bullish on that market.\nBennett also maintained an Underperform rating onAurora Cannabisshares (ACB) in a note on Wednesday, though he raised his price target to $7.49 from $3.58. He said the company’s second-quarter results, reported earlier this month, “only reinforced our concerns on its underlying business.”\n“First, Canadian sales pressures were more pronounced than we had assumed, with little improvement on the margin profile,” Bennett wrote. “Second, given the near-term debt overhang and its high cash burn rate, we raise questions marks on whether Aurora’s balance sheet is strong enough to support a potential US push.”\nThe downgrade hasn’t scared investors away, at least not yet. Canopy stock was up 0.8%, at $35.6, in recent trading. Aurora stock was up 3.8%, at $11.64.ETFMG Alternative Harvest(MJ), a cannabis-focused exchange-traded fund, was up 4.4%, while the S&P 500 was up 1.1%.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":361288612,"gmtCreate":1614239054936,"gmtModify":1634550538888,"author":{"id":"3564713729410873","authorId":"3564713729410873","name":"Lamshiying","avatar":"https://static.tigerbbs.com/0538201b20a08cd3fe6cf75cff8a6dd5","vip":1,"crmLevel":1,"crmLevelSwitch":0,"authorIdStr":"3564713729410873","idStr":"3564713729410873"},"htmlText":"Hold for long term","listText":"Hold for long term","text":"Hold for long term","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/361288612","repostId":1122955763,"repostType":4,"repost":{"id":"1122955763","pubTimestamp":1614237149,"share":"https://www.laohu8.com/m/news/1122955763?lang=&edition=full","pubTime":"2021-02-25 15:12","market":"us","language":"en","title":"This Marijuana Stock Is Now ‘Too Expensive,’ Analyst Says","url":"https://stock-news.laohu8.com/highlight/detail?id=1122955763","media":"Barrons","summary":"Canopy Growth shares were rising on Wednesday, along with its Canadian cannabis peers. An analyst at","content":"<p>Canopy Growth&nbsp;shares were rising on Wednesday, along with its Canadian cannabis peers. An analyst at Jefferies says the stock is now “too expensive.”</p>\n<p>Owen Bennett&nbsp;lowered his rating on Canopy stock (ticker: CGC) to Underperform from Hold, though he upped his price target to $23.03 from $21.10. He argues the stock’s valuation, relative to peers, is deservedly higher due to its opportunities to enter the U.S. market when it’s legal to do so. Yet he argues investors shouldn’t play U.S. legalization with the stock at these levels.</p>\n<p>As&nbsp;Barron’s&nbsp;note&nbsp;dearlier this month, popular U.S. growers includeCuraleaf Holdings(CURLF),Trulieve Cannabis(TCNNF),Green Thumb Industries(GTBIF), and&nbsp;Cresco Labs(CRLBF).</p>\n<p>Given that Canopy and the U.S. grower it has a contingent deal to acquire, Acreage Holdings, are losing money, Bennett sees other U.S. growers with superior fundamental outlooks. Meanwhile, he says, the Canadian market is still in a period of transition following industrywide missteps in the rollout of legal cannabis. While he sees some encouraging signs, he argues it is still too early to turn bullish on that market.</p>\n<p>Bennett also maintained an Underperform rating onAurora Cannabisshares (ACB) in a note on Wednesday, though he raised his price target to $7.49 from $3.58. He said the company’s second-quarter results, reported earlier this month, “only reinforced our concerns on its underlying business.”</p>\n<p>“First, Canadian sales pressures were more pronounced than we had assumed, with little improvement on the margin profile,” Bennett wrote. “Second, given the near-term debt overhang and its high cash burn rate, we raise questions marks on whether Aurora’s balance sheet is strong enough to support a potential US push.”</p>\n<p>The downgrade hasn’t scared investors away, at least not yet. Canopy stock was up 0.8%, at $35.6, in recent trading. Aurora stock was up 3.8%, at $11.64.ETFMG Alternative Harvest(MJ), a cannabis-focused exchange-traded fund, was up 4.4%, while the&nbsp;S&amp;P 500&nbsp;was up 1.1%.</p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>This Marijuana Stock Is Now ‘Too Expensive,’ Analyst Says</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThis Marijuana Stock Is Now ‘Too Expensive,’ Analyst Says\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-02-25 15:12 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.barrons.com/articles/this-cannabis-stock-is-now-too-expensive-analyst-says-51614198173?mod=hp_DAY_9><strong>Barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Canopy Growth shares were rising on Wednesday, along with its Canadian cannabis peers. An analyst at Jefferies says the stock is now “too expensive.”\nOwen Bennett lowered his rating on Canopy stock (...</p>\n\n<a href=\"https://www.barrons.com/articles/this-cannabis-stock-is-now-too-expensive-analyst-says-51614198173?mod=hp_DAY_9\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CRON":"Cronos Group Inc.","CGC":"Canopy Growth Corporation","MJ":"Amplify Alternative Harvest ETF","ACB":"奥罗拉大麻公司","APHA":"Aphria Inc.","SNDL":"SNDL Inc."},"source_url":"https://www.barrons.com/articles/this-cannabis-stock-is-now-too-expensive-analyst-says-51614198173?mod=hp_DAY_9","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1122955763","content_text":"Canopy Growth shares were rising on Wednesday, along with its Canadian cannabis peers. An analyst at Jefferies says the stock is now “too expensive.”\nOwen Bennett lowered his rating on Canopy stock (ticker: CGC) to Underperform from Hold, though he upped his price target to $23.03 from $21.10. He argues the stock’s valuation, relative to peers, is deservedly higher due to its opportunities to enter the U.S. market when it’s legal to do so. Yet he argues investors shouldn’t play U.S. legalization with the stock at these levels.\nAs Barron’s note dearlier this month, popular U.S. growers includeCuraleaf Holdings(CURLF),Trulieve Cannabis(TCNNF),Green Thumb Industries(GTBIF), and Cresco Labs(CRLBF).\nGiven that Canopy and the U.S. grower it has a contingent deal to acquire, Acreage Holdings, are losing money, Bennett sees other U.S. growers with superior fundamental outlooks. Meanwhile, he says, the Canadian market is still in a period of transition following industrywide missteps in the rollout of legal cannabis. While he sees some encouraging signs, he argues it is still too early to turn bullish on that market.\nBennett also maintained an Underperform rating onAurora Cannabisshares (ACB) in a note on Wednesday, though he raised his price target to $7.49 from $3.58. He said the company’s second-quarter results, reported earlier this month, “only reinforced our concerns on its underlying business.”\n“First, Canadian sales pressures were more pronounced than we had assumed, with little improvement on the margin profile,” Bennett wrote. “Second, given the near-term debt overhang and its high cash burn rate, we raise questions marks on whether Aurora’s balance sheet is strong enough to support a potential US push.”\nThe downgrade hasn’t scared investors away, at least not yet. Canopy stock was up 0.8%, at $35.6, in recent trading. Aurora stock was up 3.8%, at $11.64.ETFMG Alternative Harvest(MJ), a cannabis-focused exchange-traded fund, was up 4.4%, while the S&P 500 was up 1.1%.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":361283521,"gmtCreate":1614238789863,"gmtModify":1634550539934,"author":{"id":"3554930019589170","authorId":"3554930019589170","name":"新運股","avatar":"https://static.tigerbbs.com/96dbdc016b8e3ed8f796ebddecd0b2ca","vip":1,"crmLevel":4,"crmLevelSwitch":0,"authorIdStr":"3554930019589170","idStr":"3554930019589170"},"htmlText":"Expensive can become more expensive","listText":"Expensive can become more expensive","text":"Expensive can become more expensive","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/361283521","repostId":1122955763,"repostType":4,"repost":{"id":"1122955763","pubTimestamp":1614237149,"share":"https://www.laohu8.com/m/news/1122955763?lang=&edition=full","pubTime":"2021-02-25 15:12","market":"us","language":"en","title":"This Marijuana Stock Is Now ‘Too Expensive,’ Analyst Says","url":"https://stock-news.laohu8.com/highlight/detail?id=1122955763","media":"Barrons","summary":"Canopy Growth shares were rising on Wednesday, along with its Canadian cannabis peers. An analyst at","content":"<p>Canopy Growth&nbsp;shares were rising on Wednesday, along with its Canadian cannabis peers. An analyst at Jefferies says the stock is now “too expensive.”</p>\n<p>Owen Bennett&nbsp;lowered his rating on Canopy stock (ticker: CGC) to Underperform from Hold, though he upped his price target to $23.03 from $21.10. He argues the stock’s valuation, relative to peers, is deservedly higher due to its opportunities to enter the U.S. market when it’s legal to do so. Yet he argues investors shouldn’t play U.S. legalization with the stock at these levels.</p>\n<p>As&nbsp;Barron’s&nbsp;note&nbsp;dearlier this month, popular U.S. growers includeCuraleaf Holdings(CURLF),Trulieve Cannabis(TCNNF),Green Thumb Industries(GTBIF), and&nbsp;Cresco Labs(CRLBF).</p>\n<p>Given that Canopy and the U.S. grower it has a contingent deal to acquire, Acreage Holdings, are losing money, Bennett sees other U.S. growers with superior fundamental outlooks. Meanwhile, he says, the Canadian market is still in a period of transition following industrywide missteps in the rollout of legal cannabis. While he sees some encouraging signs, he argues it is still too early to turn bullish on that market.</p>\n<p>Bennett also maintained an Underperform rating onAurora Cannabisshares (ACB) in a note on Wednesday, though he raised his price target to $7.49 from $3.58. He said the company’s second-quarter results, reported earlier this month, “only reinforced our concerns on its underlying business.”</p>\n<p>“First, Canadian sales pressures were more pronounced than we had assumed, with little improvement on the margin profile,” Bennett wrote. “Second, given the near-term debt overhang and its high cash burn rate, we raise questions marks on whether Aurora’s balance sheet is strong enough to support a potential US push.”</p>\n<p>The downgrade hasn’t scared investors away, at least not yet. Canopy stock was up 0.8%, at $35.6, in recent trading. Aurora stock was up 3.8%, at $11.64.ETFMG Alternative Harvest(MJ), a cannabis-focused exchange-traded fund, was up 4.4%, while the&nbsp;S&amp;P 500&nbsp;was up 1.1%.</p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>This Marijuana Stock Is Now ‘Too Expensive,’ Analyst Says</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThis Marijuana Stock Is Now ‘Too Expensive,’ Analyst Says\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-02-25 15:12 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.barrons.com/articles/this-cannabis-stock-is-now-too-expensive-analyst-says-51614198173?mod=hp_DAY_9><strong>Barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Canopy Growth shares were rising on Wednesday, along with its Canadian cannabis peers. An analyst at Jefferies says the stock is now “too expensive.”\nOwen Bennett lowered his rating on Canopy stock (...</p>\n\n<a href=\"https://www.barrons.com/articles/this-cannabis-stock-is-now-too-expensive-analyst-says-51614198173?mod=hp_DAY_9\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CRON":"Cronos Group Inc.","CGC":"Canopy Growth Corporation","MJ":"Amplify Alternative Harvest ETF","ACB":"奥罗拉大麻公司","APHA":"Aphria Inc.","SNDL":"SNDL Inc."},"source_url":"https://www.barrons.com/articles/this-cannabis-stock-is-now-too-expensive-analyst-says-51614198173?mod=hp_DAY_9","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1122955763","content_text":"Canopy Growth shares were rising on Wednesday, along with its Canadian cannabis peers. An analyst at Jefferies says the stock is now “too expensive.”\nOwen Bennett lowered his rating on Canopy stock (ticker: CGC) to Underperform from Hold, though he upped his price target to $23.03 from $21.10. He argues the stock’s valuation, relative to peers, is deservedly higher due to its opportunities to enter the U.S. market when it’s legal to do so. Yet he argues investors shouldn’t play U.S. legalization with the stock at these levels.\nAs Barron’s note dearlier this month, popular U.S. growers includeCuraleaf Holdings(CURLF),Trulieve Cannabis(TCNNF),Green Thumb Industries(GTBIF), and Cresco Labs(CRLBF).\nGiven that Canopy and the U.S. grower it has a contingent deal to acquire, Acreage Holdings, are losing money, Bennett sees other U.S. growers with superior fundamental outlooks. Meanwhile, he says, the Canadian market is still in a period of transition following industrywide missteps in the rollout of legal cannabis. While he sees some encouraging signs, he argues it is still too early to turn bullish on that market.\nBennett also maintained an Underperform rating onAurora Cannabisshares (ACB) in a note on Wednesday, though he raised his price target to $7.49 from $3.58. He said the company’s second-quarter results, reported earlier this month, “only reinforced our concerns on its underlying business.”\n“First, Canadian sales pressures were more pronounced than we had assumed, with little improvement on the margin profile,” Bennett wrote. “Second, given the near-term debt overhang and its high cash burn rate, we raise questions marks on whether Aurora’s balance sheet is strong enough to support a potential US push.”\nThe downgrade hasn’t scared investors away, at least not yet. Canopy stock was up 0.8%, at $35.6, in recent trading. Aurora stock was up 3.8%, at $11.64.ETFMG Alternative Harvest(MJ), a cannabis-focused exchange-traded fund, was up 4.4%, while the S&P 500 was up 1.1%.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":3658559,"gmtCreate":1614238800176,"gmtModify":1635761255495,"authorId":3554930019589170,"author":{"id":3554930019589170,"idStr":"3554930019589170","authorId":3554930019589170,"name":"新運股","avatar":"https://static.tigerbbs.com/96dbdc016b8e3ed8f796ebddecd0b2ca","vip":1,"crmLevel":4,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":361283521,"type":1,"supId":0,"prevId":0,"content":"Haha","text":"Haha","html":"Haha"},{"id":3658586,"gmtCreate":1614239035990,"gmtModify":1635761254610,"authorId":3571731917050098,"author":{"id":3571731917050098,"idStr":"3571731917050098","authorId":3571731917050098,"name":"killuz","avatar":"https://static.tigerbbs.com/f2f7506133b4298111ecff9ef46ff33c","vip":1,"crmLevel":4,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":361283521,"type":1,"supId":3658559,"prevId":0,"content":"<u>hahaha</u>","text":"<u>hahaha</u>","html":"<u>hahaha</u>"}],"langContent":"EN"},{"id":361289184,"gmtCreate":1614238646848,"gmtModify":1634550540756,"author":{"id":"3573788355724268","authorId":"3573788355724268","name":"Ewald","avatar":"https://static.tigerbbs.com/60c8eb8db3c825e3fdeb89353eacb524","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3573788355724268","idStr":"3573788355724268"},"htmlText":"I don't think so...&nbsp;","listText":"I don't think so...&nbsp;","text":"I don't think so...","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/361289184","repostId":1122955763,"repostType":4,"repost":{"id":"1122955763","pubTimestamp":1614237149,"share":"https://www.laohu8.com/m/news/1122955763?lang=&edition=full","pubTime":"2021-02-25 15:12","market":"us","language":"en","title":"This Marijuana Stock Is Now ‘Too Expensive,’ Analyst Says","url":"https://stock-news.laohu8.com/highlight/detail?id=1122955763","media":"Barrons","summary":"Canopy Growth shares were rising on Wednesday, along with its Canadian cannabis peers. An analyst at","content":"<p>Canopy Growth&nbsp;shares were rising on Wednesday, along with its Canadian cannabis peers. An analyst at Jefferies says the stock is now “too expensive.”</p>\n<p>Owen Bennett&nbsp;lowered his rating on Canopy stock (ticker: CGC) to Underperform from Hold, though he upped his price target to $23.03 from $21.10. He argues the stock’s valuation, relative to peers, is deservedly higher due to its opportunities to enter the U.S. market when it’s legal to do so. Yet he argues investors shouldn’t play U.S. legalization with the stock at these levels.</p>\n<p>As&nbsp;Barron’s&nbsp;note&nbsp;dearlier this month, popular U.S. growers includeCuraleaf Holdings(CURLF),Trulieve Cannabis(TCNNF),Green Thumb Industries(GTBIF), and&nbsp;Cresco Labs(CRLBF).</p>\n<p>Given that Canopy and the U.S. grower it has a contingent deal to acquire, Acreage Holdings, are losing money, Bennett sees other U.S. growers with superior fundamental outlooks. Meanwhile, he says, the Canadian market is still in a period of transition following industrywide missteps in the rollout of legal cannabis. While he sees some encouraging signs, he argues it is still too early to turn bullish on that market.</p>\n<p>Bennett also maintained an Underperform rating onAurora Cannabisshares (ACB) in a note on Wednesday, though he raised his price target to $7.49 from $3.58. He said the company’s second-quarter results, reported earlier this month, “only reinforced our concerns on its underlying business.”</p>\n<p>“First, Canadian sales pressures were more pronounced than we had assumed, with little improvement on the margin profile,” Bennett wrote. “Second, given the near-term debt overhang and its high cash burn rate, we raise questions marks on whether Aurora’s balance sheet is strong enough to support a potential US push.”</p>\n<p>The downgrade hasn’t scared investors away, at least not yet. Canopy stock was up 0.8%, at $35.6, in recent trading. Aurora stock was up 3.8%, at $11.64.ETFMG Alternative Harvest(MJ), a cannabis-focused exchange-traded fund, was up 4.4%, while the&nbsp;S&amp;P 500&nbsp;was up 1.1%.</p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>This Marijuana Stock Is Now ‘Too Expensive,’ Analyst Says</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThis Marijuana Stock Is Now ‘Too Expensive,’ Analyst Says\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-02-25 15:12 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.barrons.com/articles/this-cannabis-stock-is-now-too-expensive-analyst-says-51614198173?mod=hp_DAY_9><strong>Barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Canopy Growth shares were rising on Wednesday, along with its Canadian cannabis peers. An analyst at Jefferies says the stock is now “too expensive.”\nOwen Bennett lowered his rating on Canopy stock (...</p>\n\n<a href=\"https://www.barrons.com/articles/this-cannabis-stock-is-now-too-expensive-analyst-says-51614198173?mod=hp_DAY_9\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CRON":"Cronos Group Inc.","CGC":"Canopy Growth Corporation","MJ":"Amplify Alternative Harvest ETF","ACB":"奥罗拉大麻公司","APHA":"Aphria Inc.","SNDL":"SNDL Inc."},"source_url":"https://www.barrons.com/articles/this-cannabis-stock-is-now-too-expensive-analyst-says-51614198173?mod=hp_DAY_9","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1122955763","content_text":"Canopy Growth shares were rising on Wednesday, along with its Canadian cannabis peers. An analyst at Jefferies says the stock is now “too expensive.”\nOwen Bennett lowered his rating on Canopy stock (ticker: CGC) to Underperform from Hold, though he upped his price target to $23.03 from $21.10. He argues the stock’s valuation, relative to peers, is deservedly higher due to its opportunities to enter the U.S. market when it’s legal to do so. Yet he argues investors shouldn’t play U.S. legalization with the stock at these levels.\nAs Barron’s note dearlier this month, popular U.S. growers includeCuraleaf Holdings(CURLF),Trulieve Cannabis(TCNNF),Green Thumb Industries(GTBIF), and Cresco Labs(CRLBF).\nGiven that Canopy and the U.S. grower it has a contingent deal to acquire, Acreage Holdings, are losing money, Bennett sees other U.S. growers with superior fundamental outlooks. Meanwhile, he says, the Canadian market is still in a period of transition following industrywide missteps in the rollout of legal cannabis. While he sees some encouraging signs, he argues it is still too early to turn bullish on that market.\nBennett also maintained an Underperform rating onAurora Cannabisshares (ACB) in a note on Wednesday, though he raised his price target to $7.49 from $3.58. He said the company’s second-quarter results, reported earlier this month, “only reinforced our concerns on its underlying business.”\n“First, Canadian sales pressures were more pronounced than we had assumed, with little improvement on the margin profile,” Bennett wrote. “Second, given the near-term debt overhang and its high cash burn rate, we raise questions marks on whether Aurora’s balance sheet is strong enough to support a potential US push.”\nThe downgrade hasn’t scared investors away, at least not yet. Canopy stock was up 0.8%, at $35.6, in recent trading. Aurora stock was up 3.8%, at $11.64.ETFMG Alternative Harvest(MJ), a cannabis-focused exchange-traded fund, was up 4.4%, while the S&P 500 was up 1.1%.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":3658551,"gmtCreate":1614238673162,"gmtModify":1635761256047,"authorId":3573199933512445,"author":{"id":3573199933512445,"idStr":"3573199933512445","authorId":3573199933512445,"name":"Shermantanjs","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":361289184,"type":1,"supId":0,"prevId":0,"content":"Wheeee","text":"Wheeee","html":"Wheeee"}],"langContent":"EN"},{"id":361280183,"gmtCreate":1614238424142,"gmtModify":1634550541339,"author":{"id":"3569371789291180","authorId":"3569371789291180","name":"Han96","avatar":"https://static.tigerbbs.com/f97b8f049cf05e776dde087d8f933617","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3569371789291180","idStr":"3569371789291180"},"htmlText":"😊","listText":"😊","text":"😊","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/361280183","repostId":1122955763,"repostType":4,"repost":{"id":"1122955763","pubTimestamp":1614237149,"share":"https://www.laohu8.com/m/news/1122955763?lang=&edition=full","pubTime":"2021-02-25 15:12","market":"us","language":"en","title":"This Marijuana Stock Is Now ‘Too Expensive,’ Analyst Says","url":"https://stock-news.laohu8.com/highlight/detail?id=1122955763","media":"Barrons","summary":"Canopy Growth shares were rising on Wednesday, along with its Canadian cannabis peers. An analyst at","content":"<p>Canopy Growth&nbsp;shares were rising on Wednesday, along with its Canadian cannabis peers. An analyst at Jefferies says the stock is now “too expensive.”</p>\n<p>Owen Bennett&nbsp;lowered his rating on Canopy stock (ticker: CGC) to Underperform from Hold, though he upped his price target to $23.03 from $21.10. He argues the stock’s valuation, relative to peers, is deservedly higher due to its opportunities to enter the U.S. market when it’s legal to do so. Yet he argues investors shouldn’t play U.S. legalization with the stock at these levels.</p>\n<p>As&nbsp;Barron’s&nbsp;note&nbsp;dearlier this month, popular U.S. growers includeCuraleaf Holdings(CURLF),Trulieve Cannabis(TCNNF),Green Thumb Industries(GTBIF), and&nbsp;Cresco Labs(CRLBF).</p>\n<p>Given that Canopy and the U.S. grower it has a contingent deal to acquire, Acreage Holdings, are losing money, Bennett sees other U.S. growers with superior fundamental outlooks. Meanwhile, he says, the Canadian market is still in a period of transition following industrywide missteps in the rollout of legal cannabis. While he sees some encouraging signs, he argues it is still too early to turn bullish on that market.</p>\n<p>Bennett also maintained an Underperform rating onAurora Cannabisshares (ACB) in a note on Wednesday, though he raised his price target to $7.49 from $3.58. He said the company’s second-quarter results, reported earlier this month, “only reinforced our concerns on its underlying business.”</p>\n<p>“First, Canadian sales pressures were more pronounced than we had assumed, with little improvement on the margin profile,” Bennett wrote. “Second, given the near-term debt overhang and its high cash burn rate, we raise questions marks on whether Aurora’s balance sheet is strong enough to support a potential US push.”</p>\n<p>The downgrade hasn’t scared investors away, at least not yet. Canopy stock was up 0.8%, at $35.6, in recent trading. Aurora stock was up 3.8%, at $11.64.ETFMG Alternative Harvest(MJ), a cannabis-focused exchange-traded fund, was up 4.4%, while the&nbsp;S&amp;P 500&nbsp;was up 1.1%.</p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>This Marijuana Stock Is Now ‘Too Expensive,’ Analyst Says</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThis Marijuana Stock Is Now ‘Too Expensive,’ Analyst Says\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-02-25 15:12 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.barrons.com/articles/this-cannabis-stock-is-now-too-expensive-analyst-says-51614198173?mod=hp_DAY_9><strong>Barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Canopy Growth shares were rising on Wednesday, along with its Canadian cannabis peers. An analyst at Jefferies says the stock is now “too expensive.”\nOwen Bennett lowered his rating on Canopy stock (...</p>\n\n<a href=\"https://www.barrons.com/articles/this-cannabis-stock-is-now-too-expensive-analyst-says-51614198173?mod=hp_DAY_9\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CRON":"Cronos Group Inc.","CGC":"Canopy Growth Corporation","MJ":"Amplify Alternative Harvest ETF","ACB":"奥罗拉大麻公司","APHA":"Aphria Inc.","SNDL":"SNDL Inc."},"source_url":"https://www.barrons.com/articles/this-cannabis-stock-is-now-too-expensive-analyst-says-51614198173?mod=hp_DAY_9","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1122955763","content_text":"Canopy Growth shares were rising on Wednesday, along with its Canadian cannabis peers. An analyst at Jefferies says the stock is now “too expensive.”\nOwen Bennett lowered his rating on Canopy stock (ticker: CGC) to Underperform from Hold, though he upped his price target to $23.03 from $21.10. He argues the stock’s valuation, relative to peers, is deservedly higher due to its opportunities to enter the U.S. market when it’s legal to do so. Yet he argues investors shouldn’t play U.S. legalization with the stock at these levels.\nAs Barron’s note dearlier this month, popular U.S. growers includeCuraleaf Holdings(CURLF),Trulieve Cannabis(TCNNF),Green Thumb Industries(GTBIF), and Cresco Labs(CRLBF).\nGiven that Canopy and the U.S. grower it has a contingent deal to acquire, Acreage Holdings, are losing money, Bennett sees other U.S. growers with superior fundamental outlooks. Meanwhile, he says, the Canadian market is still in a period of transition following industrywide missteps in the rollout of legal cannabis. While he sees some encouraging signs, he argues it is still too early to turn bullish on that market.\nBennett also maintained an Underperform rating onAurora Cannabisshares (ACB) in a note on Wednesday, though he raised his price target to $7.49 from $3.58. He said the company’s second-quarter results, reported earlier this month, “only reinforced our concerns on its underlying business.”\n“First, Canadian sales pressures were more pronounced than we had assumed, with little improvement on the margin profile,” Bennett wrote. “Second, given the near-term debt overhang and its high cash burn rate, we raise questions marks on whether Aurora’s balance sheet is strong enough to support a potential US push.”\nThe downgrade hasn’t scared investors away, at least not yet. Canopy stock was up 0.8%, at $35.6, in recent trading. Aurora stock was up 3.8%, at $11.64.ETFMG Alternative Harvest(MJ), a cannabis-focused exchange-traded fund, was up 4.4%, while the S&P 500 was up 1.1%.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":361215495,"gmtCreate":1614238096617,"gmtModify":1634550542724,"author":{"id":"3551655093075927","authorId":"3551655093075927","name":"KLS","avatar":"https://static.tigerbbs.com/60fe00969bbce4cfecf0d17a38c77628","vip":1,"crmLevel":4,"crmLevelSwitch":0,"authorIdStr":"3551655093075927","idStr":"3551655093075927"},"htmlText":"Pls comemnt on my comment&nbsp;","listText":"Pls comemnt on my comment&nbsp;","text":"Pls comemnt on my comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/361215495","repostId":1122955763,"repostType":4,"repost":{"id":"1122955763","pubTimestamp":1614237149,"share":"https://www.laohu8.com/m/news/1122955763?lang=&edition=full","pubTime":"2021-02-25 15:12","market":"us","language":"en","title":"This Marijuana Stock Is Now ‘Too Expensive,’ Analyst Says","url":"https://stock-news.laohu8.com/highlight/detail?id=1122955763","media":"Barrons","summary":"Canopy Growth shares were rising on Wednesday, along with its Canadian cannabis peers. An analyst at","content":"<p>Canopy Growth&nbsp;shares were rising on Wednesday, along with its Canadian cannabis peers. An analyst at Jefferies says the stock is now “too expensive.”</p>\n<p>Owen Bennett&nbsp;lowered his rating on Canopy stock (ticker: CGC) to Underperform from Hold, though he upped his price target to $23.03 from $21.10. He argues the stock’s valuation, relative to peers, is deservedly higher due to its opportunities to enter the U.S. market when it’s legal to do so. Yet he argues investors shouldn’t play U.S. legalization with the stock at these levels.</p>\n<p>As&nbsp;Barron’s&nbsp;note&nbsp;dearlier this month, popular U.S. growers includeCuraleaf Holdings(CURLF),Trulieve Cannabis(TCNNF),Green Thumb Industries(GTBIF), and&nbsp;Cresco Labs(CRLBF).</p>\n<p>Given that Canopy and the U.S. grower it has a contingent deal to acquire, Acreage Holdings, are losing money, Bennett sees other U.S. growers with superior fundamental outlooks. Meanwhile, he says, the Canadian market is still in a period of transition following industrywide missteps in the rollout of legal cannabis. While he sees some encouraging signs, he argues it is still too early to turn bullish on that market.</p>\n<p>Bennett also maintained an Underperform rating onAurora Cannabisshares (ACB) in a note on Wednesday, though he raised his price target to $7.49 from $3.58. He said the company’s second-quarter results, reported earlier this month, “only reinforced our concerns on its underlying business.”</p>\n<p>“First, Canadian sales pressures were more pronounced than we had assumed, with little improvement on the margin profile,” Bennett wrote. “Second, given the near-term debt overhang and its high cash burn rate, we raise questions marks on whether Aurora’s balance sheet is strong enough to support a potential US push.”</p>\n<p>The downgrade hasn’t scared investors away, at least not yet. Canopy stock was up 0.8%, at $35.6, in recent trading. Aurora stock was up 3.8%, at $11.64.ETFMG Alternative Harvest(MJ), a cannabis-focused exchange-traded fund, was up 4.4%, while the&nbsp;S&amp;P 500&nbsp;was up 1.1%.</p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>This Marijuana Stock Is Now ‘Too Expensive,’ Analyst Says</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThis Marijuana Stock Is Now ‘Too Expensive,’ Analyst Says\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-02-25 15:12 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.barrons.com/articles/this-cannabis-stock-is-now-too-expensive-analyst-says-51614198173?mod=hp_DAY_9><strong>Barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Canopy Growth shares were rising on Wednesday, along with its Canadian cannabis peers. An analyst at Jefferies says the stock is now “too expensive.”\nOwen Bennett lowered his rating on Canopy stock (...</p>\n\n<a href=\"https://www.barrons.com/articles/this-cannabis-stock-is-now-too-expensive-analyst-says-51614198173?mod=hp_DAY_9\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CRON":"Cronos Group Inc.","CGC":"Canopy Growth Corporation","MJ":"Amplify Alternative Harvest ETF","ACB":"奥罗拉大麻公司","APHA":"Aphria Inc.","SNDL":"SNDL Inc."},"source_url":"https://www.barrons.com/articles/this-cannabis-stock-is-now-too-expensive-analyst-says-51614198173?mod=hp_DAY_9","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1122955763","content_text":"Canopy Growth shares were rising on Wednesday, along with its Canadian cannabis peers. An analyst at Jefferies says the stock is now “too expensive.”\nOwen Bennett lowered his rating on Canopy stock (ticker: CGC) to Underperform from Hold, though he upped his price target to $23.03 from $21.10. He argues the stock’s valuation, relative to peers, is deservedly higher due to its opportunities to enter the U.S. market when it’s legal to do so. Yet he argues investors shouldn’t play U.S. legalization with the stock at these levels.\nAs Barron’s note dearlier this month, popular U.S. growers includeCuraleaf Holdings(CURLF),Trulieve Cannabis(TCNNF),Green Thumb Industries(GTBIF), and Cresco Labs(CRLBF).\nGiven that Canopy and the U.S. grower it has a contingent deal to acquire, Acreage Holdings, are losing money, Bennett sees other U.S. growers with superior fundamental outlooks. Meanwhile, he says, the Canadian market is still in a period of transition following industrywide missteps in the rollout of legal cannabis. While he sees some encouraging signs, he argues it is still too early to turn bullish on that market.\nBennett also maintained an Underperform rating onAurora Cannabisshares (ACB) in a note on Wednesday, though he raised his price target to $7.49 from $3.58. He said the company’s second-quarter results, reported earlier this month, “only reinforced our concerns on its underlying business.”\n“First, Canadian sales pressures were more pronounced than we had assumed, with little improvement on the margin profile,” Bennett wrote. “Second, given the near-term debt overhang and its high cash burn rate, we raise questions marks on whether Aurora’s balance sheet is strong enough to support a potential US push.”\nThe downgrade hasn’t scared investors away, at least not yet. Canopy stock was up 0.8%, at $35.6, in recent trading. Aurora stock was up 3.8%, at $11.64.ETFMG Alternative Harvest(MJ), a cannabis-focused exchange-traded fund, was up 4.4%, while the S&P 500 was up 1.1%.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":3658516,"gmtCreate":1614238265500,"gmtModify":1635761257254,"authorId":3572879474955890,"author":{"id":3572879474955890,"idStr":"3572879474955890","authorId":3572879474955890,"name":"Adnand","avatar":"https://static.tigerbbs.com/3a167e95fad81a5db5f6ebdd45212f6f","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":361215495,"type":1,"supId":0,"prevId":0,"content":"commented!","text":"commented!","html":"commented!"},{"id":3658552,"gmtCreate":1614238679595,"gmtModify":1635761255935,"authorId":3573199933512445,"author":{"id":3573199933512445,"idStr":"3573199933512445","authorId":3573199933512445,"name":"Shermantanjs","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":361215495,"type":1,"supId":0,"prevId":0,"content":"Commented","text":"Commented","html":"Commented"}],"langContent":"EN"},{"id":361216689,"gmtCreate":1614237741441,"gmtModify":1634550543787,"author":{"id":"3570445773051839","authorId":"3570445773051839","name":"Vicwoo","avatar":"https://static.tigerbbs.com/a195aa0cd9886e86982b3f2c41bf2182","vip":1,"crmLevel":5,"crmLevelSwitch":0,"authorIdStr":"3570445773051839","idStr":"3570445773051839"},"htmlText":"Hmmm","listText":"Hmmm","text":"Hmmm","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/361216689","repostId":1122955763,"repostType":4,"repost":{"id":"1122955763","pubTimestamp":1614237149,"share":"https://www.laohu8.com/m/news/1122955763?lang=&edition=full","pubTime":"2021-02-25 15:12","market":"us","language":"en","title":"This Marijuana Stock Is Now ‘Too Expensive,’ Analyst Says","url":"https://stock-news.laohu8.com/highlight/detail?id=1122955763","media":"Barrons","summary":"Canopy Growth shares were rising on Wednesday, along with its Canadian cannabis peers. An analyst at","content":"<p>Canopy Growth&nbsp;shares were rising on Wednesday, along with its Canadian cannabis peers. An analyst at Jefferies says the stock is now “too expensive.”</p>\n<p>Owen Bennett&nbsp;lowered his rating on Canopy stock (ticker: CGC) to Underperform from Hold, though he upped his price target to $23.03 from $21.10. He argues the stock’s valuation, relative to peers, is deservedly higher due to its opportunities to enter the U.S. market when it’s legal to do so. Yet he argues investors shouldn’t play U.S. legalization with the stock at these levels.</p>\n<p>As&nbsp;Barron’s&nbsp;note&nbsp;dearlier this month, popular U.S. growers includeCuraleaf Holdings(CURLF),Trulieve Cannabis(TCNNF),Green Thumb Industries(GTBIF), and&nbsp;Cresco Labs(CRLBF).</p>\n<p>Given that Canopy and the U.S. grower it has a contingent deal to acquire, Acreage Holdings, are losing money, Bennett sees other U.S. growers with superior fundamental outlooks. Meanwhile, he says, the Canadian market is still in a period of transition following industrywide missteps in the rollout of legal cannabis. While he sees some encouraging signs, he argues it is still too early to turn bullish on that market.</p>\n<p>Bennett also maintained an Underperform rating onAurora Cannabisshares (ACB) in a note on Wednesday, though he raised his price target to $7.49 from $3.58. He said the company’s second-quarter results, reported earlier this month, “only reinforced our concerns on its underlying business.”</p>\n<p>“First, Canadian sales pressures were more pronounced than we had assumed, with little improvement on the margin profile,” Bennett wrote. “Second, given the near-term debt overhang and its high cash burn rate, we raise questions marks on whether Aurora’s balance sheet is strong enough to support a potential US push.”</p>\n<p>The downgrade hasn’t scared investors away, at least not yet. Canopy stock was up 0.8%, at $35.6, in recent trading. Aurora stock was up 3.8%, at $11.64.ETFMG Alternative Harvest(MJ), a cannabis-focused exchange-traded fund, was up 4.4%, while the&nbsp;S&amp;P 500&nbsp;was up 1.1%.</p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>This Marijuana Stock Is Now ‘Too Expensive,’ Analyst Says</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThis Marijuana Stock Is Now ‘Too Expensive,’ Analyst Says\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-02-25 15:12 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.barrons.com/articles/this-cannabis-stock-is-now-too-expensive-analyst-says-51614198173?mod=hp_DAY_9><strong>Barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Canopy Growth shares were rising on Wednesday, along with its Canadian cannabis peers. An analyst at Jefferies says the stock is now “too expensive.”\nOwen Bennett lowered his rating on Canopy stock (...</p>\n\n<a href=\"https://www.barrons.com/articles/this-cannabis-stock-is-now-too-expensive-analyst-says-51614198173?mod=hp_DAY_9\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CRON":"Cronos Group Inc.","CGC":"Canopy Growth Corporation","MJ":"Amplify Alternative Harvest ETF","ACB":"奥罗拉大麻公司","APHA":"Aphria Inc.","SNDL":"SNDL Inc."},"source_url":"https://www.barrons.com/articles/this-cannabis-stock-is-now-too-expensive-analyst-says-51614198173?mod=hp_DAY_9","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1122955763","content_text":"Canopy Growth shares were rising on Wednesday, along with its Canadian cannabis peers. An analyst at Jefferies says the stock is now “too expensive.”\nOwen Bennett lowered his rating on Canopy stock (ticker: CGC) to Underperform from Hold, though he upped his price target to $23.03 from $21.10. He argues the stock’s valuation, relative to peers, is deservedly higher due to its opportunities to enter the U.S. market when it’s legal to do so. Yet he argues investors shouldn’t play U.S. legalization with the stock at these levels.\nAs Barron’s note dearlier this month, popular U.S. growers includeCuraleaf Holdings(CURLF),Trulieve Cannabis(TCNNF),Green Thumb Industries(GTBIF), and Cresco Labs(CRLBF).\nGiven that Canopy and the U.S. grower it has a contingent deal to acquire, Acreage Holdings, are losing money, Bennett sees other U.S. growers with superior fundamental outlooks. Meanwhile, he says, the Canadian market is still in a period of transition following industrywide missteps in the rollout of legal cannabis. While he sees some encouraging signs, he argues it is still too early to turn bullish on that market.\nBennett also maintained an Underperform rating onAurora Cannabisshares (ACB) in a note on Wednesday, though he raised his price target to $7.49 from $3.58. He said the company’s second-quarter results, reported earlier this month, “only reinforced our concerns on its underlying business.”\n“First, Canadian sales pressures were more pronounced than we had assumed, with little improvement on the margin profile,” Bennett wrote. “Second, given the near-term debt overhang and its high cash burn rate, we raise questions marks on whether Aurora’s balance sheet is strong enough to support a potential US push.”\nThe downgrade hasn’t scared investors away, at least not yet. Canopy stock was up 0.8%, at $35.6, in recent trading. Aurora stock was up 3.8%, at $11.64.ETFMG Alternative Harvest(MJ), a cannabis-focused exchange-traded fund, was up 4.4%, while the S&P 500 was up 1.1%.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":3658499,"gmtCreate":1614238040533,"gmtModify":1635761258024,"authorId":3551655093075927,"author":{"id":3551655093075927,"idStr":"3551655093075927","authorId":3551655093075927,"name":"KLS","avatar":"https://static.tigerbbs.com/60fe00969bbce4cfecf0d17a38c77628","vip":1,"crmLevel":4,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":361216689,"type":1,"supId":0,"prevId":0,"content":"<u>buy</u>","text":"<u>buy</u>","html":"<u>buy</u>"}],"langContent":"EN"},{"id":361211586,"gmtCreate":1614237553945,"gmtModify":1634550545179,"author":{"id":"3574587439900861","authorId":"3574587439900861","name":"DanTEOHH","avatar":"https://static.tigerbbs.com/7d9f3e9c4cc1d068ea658b0e69247a35","vip":1,"crmLevel":5,"crmLevelSwitch":0,"authorIdStr":"3574587439900861","idStr":"3574587439900861"},"htmlText":"What do you guys think?","listText":"What do you guys think?","text":"What do you guys think?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/361211586","repostId":1122955763,"repostType":4,"repost":{"id":"1122955763","pubTimestamp":1614237149,"share":"https://www.laohu8.com/m/news/1122955763?lang=&edition=full","pubTime":"2021-02-25 15:12","market":"us","language":"en","title":"This Marijuana Stock Is Now ‘Too Expensive,’ Analyst Says","url":"https://stock-news.laohu8.com/highlight/detail?id=1122955763","media":"Barrons","summary":"Canopy Growth shares were rising on Wednesday, along with its Canadian cannabis peers. An analyst at","content":"<p>Canopy Growth&nbsp;shares were rising on Wednesday, along with its Canadian cannabis peers. An analyst at Jefferies says the stock is now “too expensive.”</p>\n<p>Owen Bennett&nbsp;lowered his rating on Canopy stock (ticker: CGC) to Underperform from Hold, though he upped his price target to $23.03 from $21.10. He argues the stock’s valuation, relative to peers, is deservedly higher due to its opportunities to enter the U.S. market when it’s legal to do so. Yet he argues investors shouldn’t play U.S. legalization with the stock at these levels.</p>\n<p>As&nbsp;Barron’s&nbsp;note&nbsp;dearlier this month, popular U.S. growers includeCuraleaf Holdings(CURLF),Trulieve Cannabis(TCNNF),Green Thumb Industries(GTBIF), and&nbsp;Cresco Labs(CRLBF).</p>\n<p>Given that Canopy and the U.S. grower it has a contingent deal to acquire, Acreage Holdings, are losing money, Bennett sees other U.S. growers with superior fundamental outlooks. Meanwhile, he says, the Canadian market is still in a period of transition following industrywide missteps in the rollout of legal cannabis. While he sees some encouraging signs, he argues it is still too early to turn bullish on that market.</p>\n<p>Bennett also maintained an Underperform rating onAurora Cannabisshares (ACB) in a note on Wednesday, though he raised his price target to $7.49 from $3.58. He said the company’s second-quarter results, reported earlier this month, “only reinforced our concerns on its underlying business.”</p>\n<p>“First, Canadian sales pressures were more pronounced than we had assumed, with little improvement on the margin profile,” Bennett wrote. “Second, given the near-term debt overhang and its high cash burn rate, we raise questions marks on whether Aurora’s balance sheet is strong enough to support a potential US push.”</p>\n<p>The downgrade hasn’t scared investors away, at least not yet. Canopy stock was up 0.8%, at $35.6, in recent trading. Aurora stock was up 3.8%, at $11.64.ETFMG Alternative Harvest(MJ), a cannabis-focused exchange-traded fund, was up 4.4%, while the&nbsp;S&amp;P 500&nbsp;was up 1.1%.</p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>This Marijuana Stock Is Now ‘Too Expensive,’ Analyst Says</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThis Marijuana Stock Is Now ‘Too Expensive,’ Analyst Says\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-02-25 15:12 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.barrons.com/articles/this-cannabis-stock-is-now-too-expensive-analyst-says-51614198173?mod=hp_DAY_9><strong>Barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Canopy Growth shares were rising on Wednesday, along with its Canadian cannabis peers. An analyst at Jefferies says the stock is now “too expensive.”\nOwen Bennett lowered his rating on Canopy stock (...</p>\n\n<a href=\"https://www.barrons.com/articles/this-cannabis-stock-is-now-too-expensive-analyst-says-51614198173?mod=hp_DAY_9\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CRON":"Cronos Group Inc.","CGC":"Canopy Growth Corporation","MJ":"Amplify Alternative Harvest ETF","ACB":"奥罗拉大麻公司","APHA":"Aphria Inc.","SNDL":"SNDL Inc."},"source_url":"https://www.barrons.com/articles/this-cannabis-stock-is-now-too-expensive-analyst-says-51614198173?mod=hp_DAY_9","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1122955763","content_text":"Canopy Growth shares were rising on Wednesday, along with its Canadian cannabis peers. An analyst at Jefferies says the stock is now “too expensive.”\nOwen Bennett lowered his rating on Canopy stock (ticker: CGC) to Underperform from Hold, though he upped his price target to $23.03 from $21.10. He argues the stock’s valuation, relative to peers, is deservedly higher due to its opportunities to enter the U.S. market when it’s legal to do so. Yet he argues investors shouldn’t play U.S. legalization with the stock at these levels.\nAs Barron’s note dearlier this month, popular U.S. growers includeCuraleaf Holdings(CURLF),Trulieve Cannabis(TCNNF),Green Thumb Industries(GTBIF), and Cresco Labs(CRLBF).\nGiven that Canopy and the U.S. grower it has a contingent deal to acquire, Acreage Holdings, are losing money, Bennett sees other U.S. growers with superior fundamental outlooks. Meanwhile, he says, the Canadian market is still in a period of transition following industrywide missteps in the rollout of legal cannabis. While he sees some encouraging signs, he argues it is still too early to turn bullish on that market.\nBennett also maintained an Underperform rating onAurora Cannabisshares (ACB) in a note on Wednesday, though he raised his price target to $7.49 from $3.58. He said the company’s second-quarter results, reported earlier this month, “only reinforced our concerns on its underlying business.”\n“First, Canadian sales pressures were more pronounced than we had assumed, with little improvement on the margin profile,” Bennett wrote. “Second, given the near-term debt overhang and its high cash burn rate, we raise questions marks on whether Aurora’s balance sheet is strong enough to support a potential US push.”\nThe downgrade hasn’t scared investors away, at least not yet. Canopy stock was up 0.8%, at $35.6, in recent trading. Aurora stock was up 3.8%, at $11.64.ETFMG Alternative Harvest(MJ), a cannabis-focused exchange-traded fund, was up 4.4%, while the S&P 500 was up 1.1%.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":3658500,"gmtCreate":1614238047784,"gmtModify":1635761257914,"authorId":3551655093075927,"author":{"id":3551655093075927,"idStr":"3551655093075927","authorId":3551655093075927,"name":"KLS","avatar":"https://static.tigerbbs.com/60fe00969bbce4cfecf0d17a38c77628","vip":1,"crmLevel":4,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":361211586,"type":1,"supId":0,"prevId":0,"content":"<u>buy</u>","text":"<u>buy</u>","html":"<u>buy</u>"}],"langContent":"EN"},{"id":361213782,"gmtCreate":1614237473846,"gmtModify":1634550545537,"author":{"id":"3575615055081158","authorId":"3575615055081158","name":"XKT1234","avatar":"https://static.tigerbbs.com/63b5c62b49f5990da13bc2a032d7f702","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3575615055081158","idStr":"3575615055081158"},"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/361213782","repostId":1122955763,"repostType":4,"repost":{"id":"1122955763","pubTimestamp":1614237149,"share":"https://www.laohu8.com/m/news/1122955763?lang=&edition=full","pubTime":"2021-02-25 15:12","market":"us","language":"en","title":"This Marijuana Stock Is Now ‘Too Expensive,’ Analyst Says","url":"https://stock-news.laohu8.com/highlight/detail?id=1122955763","media":"Barrons","summary":"Canopy Growth shares were rising on Wednesday, along with its Canadian cannabis peers. An analyst at","content":"<p>Canopy Growth&nbsp;shares were rising on Wednesday, along with its Canadian cannabis peers. An analyst at Jefferies says the stock is now “too expensive.”</p>\n<p>Owen Bennett&nbsp;lowered his rating on Canopy stock (ticker: CGC) to Underperform from Hold, though he upped his price target to $23.03 from $21.10. He argues the stock’s valuation, relative to peers, is deservedly higher due to its opportunities to enter the U.S. market when it’s legal to do so. Yet he argues investors shouldn’t play U.S. legalization with the stock at these levels.</p>\n<p>As&nbsp;Barron’s&nbsp;note&nbsp;dearlier this month, popular U.S. growers includeCuraleaf Holdings(CURLF),Trulieve Cannabis(TCNNF),Green Thumb Industries(GTBIF), and&nbsp;Cresco Labs(CRLBF).</p>\n<p>Given that Canopy and the U.S. grower it has a contingent deal to acquire, Acreage Holdings, are losing money, Bennett sees other U.S. growers with superior fundamental outlooks. Meanwhile, he says, the Canadian market is still in a period of transition following industrywide missteps in the rollout of legal cannabis. While he sees some encouraging signs, he argues it is still too early to turn bullish on that market.</p>\n<p>Bennett also maintained an Underperform rating onAurora Cannabisshares (ACB) in a note on Wednesday, though he raised his price target to $7.49 from $3.58. He said the company’s second-quarter results, reported earlier this month, “only reinforced our concerns on its underlying business.”</p>\n<p>“First, Canadian sales pressures were more pronounced than we had assumed, with little improvement on the margin profile,” Bennett wrote. “Second, given the near-term debt overhang and its high cash burn rate, we raise questions marks on whether Aurora’s balance sheet is strong enough to support a potential US push.”</p>\n<p>The downgrade hasn’t scared investors away, at least not yet. Canopy stock was up 0.8%, at $35.6, in recent trading. Aurora stock was up 3.8%, at $11.64.ETFMG Alternative Harvest(MJ), a cannabis-focused exchange-traded fund, was up 4.4%, while the&nbsp;S&amp;P 500&nbsp;was up 1.1%.</p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>This Marijuana Stock Is Now ‘Too Expensive,’ Analyst Says</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThis Marijuana Stock Is Now ‘Too Expensive,’ Analyst Says\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-02-25 15:12 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.barrons.com/articles/this-cannabis-stock-is-now-too-expensive-analyst-says-51614198173?mod=hp_DAY_9><strong>Barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Canopy Growth shares were rising on Wednesday, along with its Canadian cannabis peers. An analyst at Jefferies says the stock is now “too expensive.”\nOwen Bennett lowered his rating on Canopy stock (...</p>\n\n<a href=\"https://www.barrons.com/articles/this-cannabis-stock-is-now-too-expensive-analyst-says-51614198173?mod=hp_DAY_9\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CRON":"Cronos Group Inc.","CGC":"Canopy Growth Corporation","MJ":"Amplify Alternative Harvest ETF","ACB":"奥罗拉大麻公司","APHA":"Aphria Inc.","SNDL":"SNDL Inc."},"source_url":"https://www.barrons.com/articles/this-cannabis-stock-is-now-too-expensive-analyst-says-51614198173?mod=hp_DAY_9","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1122955763","content_text":"Canopy Growth shares were rising on Wednesday, along with its Canadian cannabis peers. An analyst at Jefferies says the stock is now “too expensive.”\nOwen Bennett lowered his rating on Canopy stock (ticker: CGC) to Underperform from Hold, though he upped his price target to $23.03 from $21.10. He argues the stock’s valuation, relative to peers, is deservedly higher due to its opportunities to enter the U.S. market when it’s legal to do so. Yet he argues investors shouldn’t play U.S. legalization with the stock at these levels.\nAs Barron’s note dearlier this month, popular U.S. growers includeCuraleaf Holdings(CURLF),Trulieve Cannabis(TCNNF),Green Thumb Industries(GTBIF), and Cresco Labs(CRLBF).\nGiven that Canopy and the U.S. grower it has a contingent deal to acquire, Acreage Holdings, are losing money, Bennett sees other U.S. growers with superior fundamental outlooks. Meanwhile, he says, the Canadian market is still in a period of transition following industrywide missteps in the rollout of legal cannabis. While he sees some encouraging signs, he argues it is still too early to turn bullish on that market.\nBennett also maintained an Underperform rating onAurora Cannabisshares (ACB) in a note on Wednesday, though he raised his price target to $7.49 from $3.58. He said the company’s second-quarter results, reported earlier this month, “only reinforced our concerns on its underlying business.”\n“First, Canadian sales pressures were more pronounced than we had assumed, with little improvement on the margin profile,” Bennett wrote. “Second, given the near-term debt overhang and its high cash burn rate, we raise questions marks on whether Aurora’s balance sheet is strong enough to support a potential US push.”\nThe downgrade hasn’t scared investors away, at least not yet. Canopy stock was up 0.8%, at $35.6, in recent trading. Aurora stock was up 3.8%, at $11.64.ETFMG Alternative Harvest(MJ), a cannabis-focused exchange-traded fund, was up 4.4%, while the S&P 500 was up 1.1%.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":3658524,"gmtCreate":1614238317866,"gmtModify":1635761256818,"authorId":3546933005981745,"author":{"id":3546933005981745,"idStr":"3546933005981745","authorId":3546933005981745,"name":"francis3","avatar":"https://static.tigerbbs.com/5a5e1b786e43023ae6f9a0dc560e3dd6","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":361213782,"type":1,"supId":0,"prevId":0,"content":"But not hood","text":"But not hood","html":"But not hood"}],"langContent":"EN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":23,"commentSize":19,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}